Sign In to Follow Application
View All Documents & Correspondence

Herbicidal Composition For Wide Array Weed Management

Abstract: ABSTRACT HERBICIDAL COMPOSITION FOR WIDE-ARRAY WEED MANAGEMENT The present invention relates to a composition comprising a synergistic combination of a compound pinoxaden; in combination with chlorimuron ethyl or imazethapyr; and at least one additional herbicide compound for controlling weeds specifically for controlling weeds growing amongst crop plants. The invention further relates to formulations and methods of controlling undesired plants with the composition.

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
19 March 2024
Publication Number
39/2025
Publication Type
INA
Invention Field
CHEMICAL
Status
Email
Parent Application

Applicants

RAJDHANI PETROCHEMICALS PRIVATE LIMITED
6B, Basement, Lalita complex, Opp, HDFC Bank, 352/3 Rasala Road, Navrangpura Ahmedabad Gujarat India 380009

Inventors

1. DIPAKKUMAR PATEL
Rajdhani Petrochemicals Private Limited, 6B, Basement, Lalita complex, Opp, HDFC Bank, 352/3 Rasala Road, Navrangpura Ahmedabad Gujarat India 380009
2. BHAVESH V SHAH
Rajdhani Petrochemicals Private Limited, 6B, Basement, Lalita complex, Opp, HDFC Bank, 352/3 Rasala Road, Navrangpura Ahmedabad Gujarat India 380009
3. KENAL V SHAH
Rajdhani Petrochemicals Private Limited, 6B, Basement, Lalita complex, Opp, HDFC Bank, 352/3 Rasala Road, Navrangpura Ahmedabad Gujarat India 380009

Specification

DESC:FORM 2
THE PATENTS ACT, 1970
(39 of 1970)
&
THE PATENTS RULES, 2003
COMPLETE SPECIFICATION
[See section 10, Rule 13]

HERBICIDAL COMPOSITION FOR WIDE-ARRAY WEED MANAGEMENT

RAJDHANI PETROCHEMICALS PRIVATE LIMITED, of 6B, Basement, Lalita complex, Opp, HDFC Bank, 352/3, Rasala Road, Navrangpura, Ahmedabad-380009, Gujarat, India

THE FOLLOWING SPECIFICATION PARTICULARLY DESCRIBES THE INVENTION AND THE MANNER IN WHICH IT IS TO BE PERFORMED.

FIELD OF THE INVENTION

The present disclosure generally relates to the field of herbicides. Particularly, the present disclosure provides a composition comprising a compound pinoxaden; in combination with chlorimuron ethyl or imazethapyr; and at least one additional herbicide compound for controlling weeds specifically for controlling weeds growing amongst crop plants.

BACKGROUND OF THE INVENTION
Background description includes information that may be useful in understanding the present invention. It is not an admission that any of the information provided herein is prior art or relevant to the present invention, or that any publication specifically or implicitly referenced is prior art.

Various chemical compounds have been developed and used as herbicides for controlling different weeds growing along with crop plants and competing with them and thereby overtaking the crop plants in the field and resulting into loss for farmers. Success of controlling weeds depends upon various factors including mode of action, dose and rate of application of herbicide, specificity of herbicide in controlling particular weeds, mechanism of dissipation herbicide and other factors. To compensate the specificity of the herbicide to control only limited number of species of weeds, loss of herbicide due to dissipation and other such reasons, to improve the weedicide effect, different herbicides are applied simultaneously at much higher rates leading to antagonistic effect of different herbicides when applied together thereby resulting into ineffective weed control, resistance to such herbicides due to their continued application at much higher doses and harmful effects on crop plants leading to loss of crops in the field.

It is well known that some of the acetyl-CoA carboxylase (ACCase) inhibitors can function as herbicide. In particular, it is well known that some of the phenylpyrazole class of compounds possess ACCase inhibiting properties and hence, can function as herbicide. Among phenylpyrazole class, Pinoxaden is being investigated as a post-emergence herbicide for the control of annual grass weeds in cereal crops. However, compounds other than Pinoxaden, which fall under the phenylpyrazole class of compounds and which possess ACCase inhibiting properties are also under investigation. Likewise, compounds which do not fall under the phenylpyrazole class of compounds and which possess ACCase inhibiting properties are also under investigation.

It is well known that due to evolutionary process, the herbs may develop resistance against what was originally considered as a “lethal dose of herbicide”, in which case, the farmer may be forced to apply more amount of the herbicide to attain the same or lesser result. Application of herbicide which is greater than what was originally considered as “lethal dose of herbicide” has several disadvantages. Also, specific herbicides are tailor made taking into consideration specific type of crop and specific type of herb and does not provide wide-spectrum protection.

While it is a common belief that mixing different herbicides may be beneficial as compared to singular herbicide, there is no clear guideline as to: (a) what types of inhibitors / classes of compounds / specific compounds should be mixed, (b) in what proportions, the inhibitors / class of compounds / specific compounds should be mixed, (c) there is no guarantee that the intended purpose would be attained, wherein the intended purpose could be any of delaying development of resistance, reduction in quantity of dose which functions as the lethal dose, or a wide-spectrum control against many types of herbes, etc.

Therefore, attempts have been made to provide compositions comprising different herbicides to overcome one or more drawbacks mentioned above with the conventional manner of use of different herbicides together at higher rates. However, such attempts have not be successful in providing the effective composition comprising different herbicides. Thus, there still exists an unmet need in the art to provide compositions comprising different herbicides, wherein different herbicides comprised in the composition do not counteract each other’s action but provide synergistic effect, the composition is stable, can minimize or curtail toxic or harmful effect on crop plants, help in reducing the dose and rate of application and effective on array of different weeds.

Thus, there exists a need to develop additional combinations of herbicides which possesses at least one capacity to delay development of resistance, capacity to reduce quantity of dose which functions as the lethal dose, or capacity to act as a wide-spectrum control against many types of herbes, etc.

OBJECTS OF THE INVENTION

An object of the present invention is to provide a composition comprising combination of compounds having synergistic herbicidal effect.
Another object of the present invention is to provide a composition comprising herbicides, said composition being stable.

Yet another object of the present invention is to provide a composition comprising herbicide compounds for effective control of wide array of weeds.

SUMMARY OF THE INVENTION

This summary is provided to introduce a selection of concepts in a simplified form that are further described below in Detailed Description section. This summary is not intended to identify key features or essential features of the subject matter of the present invention, nor is it intended to be used as an aid in determining the scope of the subject matter disclosed herein.

In one aspect the present disclosure provides a stable composition comprising combination of herbicide compounds.

In an embodiment the present invention provides a composition comprising compounds having synergistic herbicidal effect.

In another embodiment the present disclosure provides a composition comprising synergistic combination of herbicide compounds for effective control of wide array of weeds.

In an embodiment there is provided a composition comprising a herbicide compound pinoxaden; in combination with chlorimuron ethyl or imazethapyr; and at least one additional herbicide compound for controlling weeds specifically for controlling weeds growing amongst crop plants.

In one embodiment, at least one additional herbicide to be included in the composition in accordance with the present invention may be selected from the group consisting of but not limited to fomesafen sodium, acifluorfen sodium, lactofen, bentazone, imazamox or imazethapyr.

In one embodiment the composition comprises effective amount of herbicide compounds for exhibiting herbicidal activity.

The concentration of the compound pinoxaden ranges from about 02 % to about 20% w/w by weight of the composition. The concentration of the compound chlorimuron ethyl or imazethapyr ranges from about 0.25% about 40% w/w by weight of the composition. The concentration of at least one additional compound can range from about 01% to about 45% w/w by weight of the composition.

In an aspect of the present invention, a herbicide composition comprising;
• a first compound being pinoxaden;
• a second compound selected from chlorimuron ethyl, imazethapyr and combination thereof; and
• a third herbicidal compound that is different from the first compound and the second compound.

In an embodiment of the invention, the ratio of first compound: second compound: third compound is 2 to 20: 0.25 to 40: 1 to 45 respectively.

In an embodiment of the invention, the third compound is selected from a group comprising of fomesafen sodium, acifluorfen sodium, lactofen, bentazone, imazamox, imazethapyr, and mixtures thereof.

In an embodiment of the invention, being in a form selected from a group comprising of capsule suspension (CS), dispersible concentrate (DC), emulsifiable concentrate (EC), water-in-oil emulsion (EO), oil in water emulsion (EW), micro-emulsion (ME), oil dispersion (OD), oil miscible flowable concentrate, oil miscible suspension (OF), oil miscible liquid (OL), suspension concentrate (SC), suspo-emulsion (SE), soluble concentrate (SL), water dispersible granule (WG or WDG), water soluble granule (SG), water soluble powder (SP), wettable powder (WP), a mixed formulation of CS and SC (ZC), a mixed formulation of CS and SE (ZE) and a mixed formulation of CS and EW (ZW).

In an embodiment of the invention, at least one of
• the herbicidal composition being in form of capsule suspension (CS) formulation, the CS formulation comprises one or more of a wall forming agent, a dispersing agent, a wetting agent, a wetting-spreading-penetrating agent, a solvent, a thickener, a suspending agent, an antifoaming agent, an antifreezing agent, a preservative and a buffering agent,
• the herbicidal composition being in a form emulsifiable concentrate (EC) formulation comprise one or more of solvent, emulsifiers, wetting agent,
• the herbicidal composition being in a form of a micro-Emulsion (ME) formulation, the ME formulation comprises one or more of Solvent, Spreading cum wetting agent,
• the herbicidal composition being in a form an oil dispersion (OD) formulation, the OD formulation comprises one or more of super wetting-spreading-penetrating agent, solvent, dispersing agents, emulsifier, Stabilizers, Antifoaming agent, Anti-freezing agent, preservative, buffering agent, Polar Co-solvent,
• the herbicidal composition being in a form a suspension Concentrate (SC) formulation, the SC formulation comprises one or more of wetting agent, dispersing agent, Suspending agent, Antifoaming agent, Anti-freezing agent, Preservatives, Thickeners,
• the herbicidal composition being in a form of a Suspo Emulsion (SE) formulation, the SE formulation comprises one or more of Solvent, Emulsifier, Stabilizer, Anti-freezing agent, Antifoaming agent, suspending agent, Wetting agent, Wetting-spreading-penetrating agent, Preservatives, Thickeners, dispersing agent, Buffering agent
• the herbicidal composition being in a form of a Wettable Granule (WG) formulation, the WG formulation comprises one or more of Dispersing agents, Wetting agents, Antifoaming agent, Carrier.

In an embodiment of the invention, the herbicide composition as claimed in claim 1, wherein:
• the composition comprising Pinoxaden, Imazethapyr and acifluorfen sodium, a ratio between Pinoxaden: Imazethapyr: acifluorfen sodium being 1: 1.5: 3 and being in an EC formulation;
• the composition comprising Pinoxaden, Imazethapyr and Fomesafen sodium, a ratio between Pinoxaden: Imazethapyr: Fomesafen sodium being 1: 1.5: 3.4 and being in a ME formulation;
• the composition comprising Pinoxaden, Chlorimuron Ethyl and Fomesafen sodium, a ratio between Pinoxaden: Imazethapyr: Fomesafen sodium being 1: 0.16: 3.4 and being in a ME formulation;
• the composition comprising Pinoxaden, Chlorimuron Ethyl and Fomesafen sodium, a ratio between Pinoxaden: Chlorimuron Ethyl: Fomesafen sodium being 1: 0.16: 3.6 and being in a WG formulation;
• the composition comprising Pinoxaden, Chlorimuron Ethyl and Imazethapyr, a ratio between Pinoxaden: Chlorimuron Ethyl: Imazethapyr being 2: 0.32: 3 and being in a WG formulation; and
• the composition comprising Pinoxaden, Imazethapyr and Imazamox, a ratio between Pinoxaden: Imazethapyr: Imazamox being 4: 3: 3 and being in a WG formulation.

In an embodiment of the invention, the process for preparation of a herbicide composition comprising;
• mixing the first compound pinoxaden;
• mixing the second compound chlorimuron ethyl, imazethapyr and combination thereof; and
• mixing the third herbicidal compound to obtain an herbicide composition.

In an embodiment of the invention, at least one of;
• a ratio of the first compound: second compound: third compound is 2 to 20: 0.25 to 40: 1 to 45;
• the third compound is selected from a group comprising of fomesafen sodium, acifluorfen sodium, lactofen, bentazone, imazamox, imazethapyr, and mixtures thereof;
• herbicide composition is in a form selected from a group comprising of capsule suspension (CS), dispersible concentrate (DC), emulsifiable concentrate (EC), water-in-oil emulsion (EO), oil in water emulsion (EW), micro-emulsion (ME), oil dispersion (OD), oil miscible flowable concentrate, oil miscible suspension (OF), oil miscible liquid (OL), suspension concentrate (SC), suspo-emulsion (SE), soluble concentrate (SL), water dispersible granule (WG or WDG), water soluble granule (SG), water soluble powder (SP), wettable powder (WP), a mixed formulation of CS and SC (ZC), a mixed formulation of CS and SE (ZE) and a mixed formulation of CS and EW (ZW).

In an embodiment of the invention, at least one of;
• the composition being an EC formulation comprising Pinoxaden, Imazethapyr and acifluorfen sodium, mixing Pinoxaden, Imazethapyr and acifluorfen sodium in a ratio between Pinoxaden: Imazethapyr: acifluorfen sodium 1: 1.5: 3 and a one more agriculturally acceptable excipient selected form a group comprising Emulsifiers, Sticker, surface tension reducer, binder, Spreader, sticker, penetrant, surface tension reducer wetting agent in one or more solvent,
• the composition being an ME formulation comprising Pinoxaden, Imazethapyr and Fomesafen sodium, mixing Pinoxaden, Imazethapyr and Fomesafen sodium in a ratio between Pinoxaden: Imazethapyr: Fomesafen sodium 0.5: 0.75: 1.7 and a one more agriculturally acceptable excipient selected form the group emulsifier, in one or more solvent,
• the composition being an ME formulation comprising Pinoxaden, Chlorimuron Ethyl and Fomesafen sodium, mixing Pinoxaden, Chlorimuron Ethyl and Fomesafen sodium in a ratio between Pinoxaden: Chlorimuron Ethyl: Fomesafen sodium 0.5: 0.75: 1.7 and a one more agriculturally acceptable excipient selected form the group emulsifier, in one or more solvent,
• the composition being an WG formulation comprising Pinoxaden, Chlorimuron Ethyl and Fomesafen sodium, mixing Pinoxaden, Chlorimuron Ethyl and Fomesafen sodium in a ratio between Pinoxaden: Chlorimuron Ethyl: Fomesafen sodium 1: 0.16: 3.6 and a one more agriculturally acceptable excipient selected form the group comprising one or more of Dispersing agents, Wetting agents, Antifoaming agent, Humectant in one or more Carrier,
• the composition being an WG formulation comprising Pinoxaden, Chlorimuron Ethyl and Imazethapyr, mixing Pinoxaden, Chlorimuron Ethyl and Imazethapyr in a ratio between Pinoxaden: Chlorimuron Ethyl: Imazethapyr 2: 0.32: 3 and a one more agriculturally acceptable excipient selected form the group comprising one or more of Dispersing agents, Wetting agents, Antifoaming agent, Humectant in one or more Carrier,
• the composition being an WG formulation comprising Pinoxaden: Imazethapyr: Imazamox, mixing Pinoxaden: Imazethapyr: Imazamox in a ratio between Pinoxaden: Imazethapyr: Imazamox 4: 3: 3 and a one more agriculturally acceptable excipient selected form the group comprising one or more of Dispersing agents, Wetting agents, Antifoaming agent, Humectant in one or more Carrier.
Other aspects of the invention will be set forth in the description which follows, and in part will be apparent from the description, or may be learnt by the practice of the invention.

DETAILED DESCRIPTION OF THE INVENTION

The following is a detailed description of embodiments of the disclosure. The embodiments are in such detail as to clearly communicate the disclosure. However, the amount of detail offered is not intended to limit the anticipated variations of embodiments; on the contrary, the intention is to cover all modifications, equivalents, and alternatives falling within the scope of the present disclosure.

All publications herein are incorporated by reference to the same extent as if each individual publication or patent application were specifically and individually indicated to be incorporated by reference. Where a definition or use of a term in an incorporated reference is inconsistent or contrary to the definition of that term provided herein, the definition of that term provided herein applies and the definition of that term in the reference does not apply.

Reference throughout this specification to “one embodiment” or “an embodiment” means that a particular feature, structure or characteristic described in connection with the embodiment is included in at least one embodiment. Thus, the appearances of the phrases “in one embodiment” or “in an embodiment” in various places throughout this specification are not necessarily all referring to the same embodiment. Furthermore, the particular features, structures, or characteristics may be combined in any suitable manner in one or more embodiments.

In some embodiments, numbers have been used for quantifying weights, percentages, ratios, and so forth, to describe certain embodiments of the invention and are to be understood as being modified in some instances by the term “about.”

The term “about” when used in conjunction with any figure would mean + 10% of said figure. Accordingly, in some embodiments, the numerical parameters set forth in the written description are approximations that can vary depending upon the desired properties sought to be obtained by a particular embodiment. In some embodiments, the numerical parameters should be construed in light of the number of reported significant digits and by applying ordinary rounding techniques. Notwithstanding that the numerical ranges and parameters setting forth the broad scope of some embodiments of the invention are approximations, the numerical values set forth in the specific examples are reported as precisely as practicable. The numerical values presented in some embodiments of the invention may contain certain errors necessarily resulting from the standard deviation found in their respective testing measurements.

Various terms as used herein are shown below. To the extent a term used is not defined below, it should be given the broadest definition persons in the pertinent art have given that term as reflected in printed publications and issued patents at the time of filing.

As used in the description herein that follow, the meaning of “a,” “an,” and “the” includes plural reference unless the context clearly dictates otherwise. Also, as used in the description herein, the meaning of “in” includes “in” and “on” unless the context clearly dictates otherwise.

Unless the context requires otherwise, throughout the specification which follow, the word “comprise” and variations thereof, such as, “comprises” and “comprising” are to be construed in an open, inclusive sense that is as “including, but not limited to.”

The recitation of ranges of values herein is merely intended to serve as a short hand method of referring individually to each separate value falling within the range. Unless otherwise indicated herein, each individual value is incorporated into the specification as if it were individually recited herein.

All methods described herein can be performed in any suitable order unless otherwise indicated herein or otherwise clearly contradicted by context. The use of any and all examples, or exemplary language (e.g. “such as”) provided with respect to certain embodiments herein is intended merely to better illuminate the invention and does not pose a limitation on the scope of the invention.

Groupings of alternative elements or embodiments of the invention disclosed herein are not to be construed as limitations. Each group member can be referred to individually or in any combination with other members of the group or other elements found herein. One or more members of a group can be included in, or deleted from, a group for reasons of convenience and/or patentability. When any such inclusion or deletion occurs, the specification is herein deemed to contain the group as modified.

The description that follows, and the embodiments described therein, is provided by way of illustration of an example, or examples, of particular embodiments of the principles and aspects of the present disclosure. These examples are provided for the purposes of explanation, and not of limitation, of those principles and of the disclosure.

It should also be appreciated that the present disclosure can be implemented in numerous ways, including as a composition, a formulation, a kit comprising the herbicide compounds or composition or formulations thereof, a method of applying the compositions or formulation provided in accordance with the present invention for controlling weeds.

The following disclosure provides many exemplary embodiments of the inventive subject matter. Although each embodiment represents a single combination of inventive elements, the inventive subject matter is considered to include all possible combinations of the disclosed elements. Thus, if one embodiment comprises elements A, B, and C, and a second embodiment comprises elements B and D, then the inventive subject matter is also considered to include other remaining combinations of A, B, C, or D, even if not explicitly disclosed.

As described herein, the term ‘effective amount of’ is used to imply the amount of the herbicide compound used in the composition or the amount of composition or the amount of formulation in accordance with the present invention that is necessary for the elimination, prevention or curb of growth of unwanted or undesired plants and vegetation referred as weeds without causing harmful effect to crop plants. The effective amount may be dependent on the time, soil, target weeds, crops and environmental conditions at the time of application.

The present invention relates to a composition comprising synergistic combination of herbicide compounds for effective control of wide array of weeds.

In one embodiment of the present invention there is provided a composition comprising a herbicide compound pinoxaden; in combination with chlorimuron ethyl or imazethapyr; and at least one additional herbicide compound for controlling wide array of weeds growing amongst crop plants.

The herbicide compound pinoxaden (8-(2,6-diethyl-p-tolyl)-1,2,4,5-tetrahydro-7-oxo-7H-pyrazolo [1,2-d] [1,4,5] oxadiazepin-9-yl 2,2-dimethyl propionate) used as one of the active ingredients in the composition of the present invention is a compound belonging to the phenylpyrazole class of chemical compounds. It is a post-emergence herbicide for the control of annual grass weeds in cereal crops. It’s herbicidal property is due to the inhibition of acetyl-CoA carboxylase (ACCase). It has the structure as per Formula I:

Formula I
The herbicide compound chlorimuron ethyl (2-([(4-chloro-6-methoxypyrimidine-2-yl)amino carbonyl]amino sulfonyl)benzoic acid, ethyl ester) is a member of the class of sulfonylurea. It is a pre and post- emergence herbicide that inhibits plant acetolactate synthase (ALS), an enzyme required for the biosynthesis of valine and isoleutine. It has the structure as per Formula II

Formula II

The herbicide compound imazethapyr (2-[4.5-dihydro-4-methyl-4-(1 -methylethyl)-5-oxo-lH-imidazol- 2-yl]-5-ethyl-3-pyridinecarboxylic acid) is a member of the class of imidazolinone. It is a herbicide that inhibits plant acetolactate synthase (ALS), an enzyme catalyzes the first common step in the biosynthesis of branched-chain amino acids: valine, leucine and isoleucine. This metabolic pathway plays an important role in plants. It has the structure as per Formula III.

Formula III

In one embodiment, the additional herbicide to be included in the composition in accordance with the present invention can be selected from the group consisting of but not limiting to fomesafen sodium, acifluorfen sodium, lactofen, bentazone, imazamox or imazethapyr.

Fomesafen sodium is an herbicide used for control of broadleaf weeds. Fomesafen products are formulated as the sodium salt and the concentration of the active ingredient in the formulation is expressed in terms of the acid equivalent (ae). Fomesafen sodium is in the diphenylether chemical class and it mode of action is via inhibition of protoporphyrinogen oxidase (PPO) in the plant.

Sodium acifluorfen is an herbicide for post-emergent weed control on agricultural crops and for residential spot treatment.

Lactofen is a broad spectrum pre and post emergence herbicide used for the control of broadleaf weeds.

Bentazone, is a post-emergence herbicide. The mode of action is based primarily on an irreversible blockage of the photosynthetic electron transport and in further consequence the inhibition of photosynthesis at photo system II.

Imazamox is used for control of most annual and perennial broadleaf weeds and grasses, woody species, and riparian and emergent aquatic weed species. Imazamox is a member of the imidazolinone class of herbicides.

The individual herbicides belonging to different class of chemicals are suitable for controlling limited species of weeds growing with only few crops like soybean, groundnut/Peanut, green gram, and few others. Surprisingly the composition comprising pinoxaden; in combination with chlorimuron ethyl or imazethapyr; and at least one additional herbicide selected from fomesafen sodium, acifluorfen sodium, lactofen, bentazone, imazamox or imazethapyr act synergistically that can control array of diverse weeds growing amongst large number of crop plants.

In an embodiment the composition comprises effective amount of herbicide compounds for exhibiting synergistic herbicidal activity on wide array of weeds.

In another embodiment, the concentration of the compound pinoxaden ranges from about 02 % to about 20% w/w by weight of the composition.

In another embodiment, the concentration of the compound chlorimuron ethyl or imazethapyr ranges from about 0.25% about 40% w/w by weight of the composition.

In yet another embodiment, the concentration of at least one additional compound can range from about 01% to about 45% w/w by weight of the composition.

In an embodiment, the herbicidal composition can control and shows broad spectrum activity and upto 99% reduction in weeds. In an embodiment, the herbicidal composition shows at least 50%, at least 60%, at least 70%, at least 80%, at least 90%, at least 95% or at least 99% reduction in weeds.

In another embodiment, the composition may be used for the control of the growth, proliferation or germination of weeds.

In another embodiment, the composition of present disclosure can be used to controls all kind of monocots, dicots and sedges weeds. The present invention also controls annual and perennial weeds. The most common weeds controlled by present inventions are Abutilon indicum, Acalypha indica, Acanthospermumhispidum, Achyranthes aspera, Aerva tomentosa, Ageratum conyzoides, Alhagicamelorum, Amaranthus hybridus, Amaranthus spinosus, Amaranthus viridis, Ammanniabaccifera, Anagallis arvensis, Argemone mexicana, Artemisia nilagiricia, Asphodelus tenuifolius, Avenafatua, Avenaludoviciana, Bidens pilosa, Boerhaaviadiffusa, Boerhaviarepanda, Brachiariamutica, Brassica kaber, Bromus tectorum, Calotropis gigantea, Cannabis sativa, Carthamus axyacantha, Cassia tora, Celosia argentea, Centella asiatica, Chenopodium album, Chenopodium murale, Chloris barbata, Chrozophorarottlerii, Cichorium intybus, Cirsium arvense, Clitoriaternatea, Cnicus arvensis, Commelinabenghalensis, Commelina communis, Convolvulus arvensis, Conyza canadensis, Corchorus acutangulus, Coronopusdidymus, Crotalaria serice, Cucumis callosus, Cuscuta campestris, Cuscuta chinensis, Cynodondactylon, Cyanotisaxillaris, Cyperus esculenthus, Cyperus iria, Cyperus rotundus, Dactylocteniumaegyptium, Datura stramonium, Daucus carota, Digera arvensis, Digitariasanguinalis, Dinebraretroflexa, Echinocholacolonum, Echinocholacrusgalli, Eclipta alba, Eichhornia crassipes, Elephantopusscaber, Eleusine indica, Eragrostis major, Euphorbia geniculata, Euphorbia hirta, Fimbristylismiliacea, Fumaria indica, Gynandropsisgynandra, Heliotropium indicum, Indigofera glandulosa, Ipomea aquatica, Lantana camara, Lathyrus aphaca, Launaeaasplenifolia, Launaea nudicaulis, Leucas aspera, Ludwigia parviflora, Marsilea quadrifoliata, Medicago denticulate, Mimosa pudica, Melilotus alba, Melilotus indica, Ocimumcanum, Oenothera biennis, Opuntia dillenil, Orobancheramosa, Oryza longistaminata, Oryza sativa, Oxalis corniculata, Oxalis latifolia, Parthenium hysterophorus, Paspalum sanguinale, Phalaris minor, Phyllanthus niruri, Physalis minima, Polypogonmonspeliensis, Portulaca oleracea, Prosopis juliflora, Rumex dentatus, Saccharum spontaneum, Scirpus spp., Stearia glauca, Seteria viridis, Sida spinosa, Silene antirrhina, Sisymbrium irio, Solanum nigrum, Solanum surattense, Sonchus oleraceous, Sorghum halepense, Spergula arvensis, SphenocleazeylanicaGaertn, Striga asiatica, Tagetes minuta, Trianthemamonogyna, Trianthemaportulacastrum, Tribulus terrestris, Trigoneliapolycerata, Vernonia cinerea, Vicia sativa and Xanthium strumarium.

In an embodiment, the composition of present disclosure can be used to controls Monocotyledonous harmful plants of the genera: Aegilops, Agropyron, Agrostis, Alopecurus, Apera, Avena, Brachiaria, Bromus, Cenchrus, Commelina, Cynodon, Cyperus, Dactyloctenium, Digitaria, Echinochloa, Eleocharis, Eleusine, Eragrostis, Erio-chloa, Festuca, Fimbristylis, Heteranthera, Imperata, Ischaemum, Leptochloa, Lolium, Monochoria, Panicum, Paspalum, Phalaris, Phleum, Poa, Rottboellia, Sagittaria, Scirpus, Setaria, Sorghum.

In another embodiment, the composition of present disclosure can be used to controls Dicotyledonous weeds of the genera: Abutilon, Amaranthus, Ambrosia, Anoda, Anthemis, Aphanes, Artemisia, Atriplex, Bellis, Bidens, Capsella, Carduus, Cassia, Centaurea, Chenopodium, Cirsium, Convolvulus, Datura, Desmodium, Emex, Erysimum, Euphorbia, Galeopsis, Galinsoga, Galium, Hibiscus, Ipomoea, Kochia, Lamium, Lepidium, Lindernia, Matricaria, Mentha, Mercurialis, Mullugo, Myosotis, Papaver, Pharbitis, Plantago, Polygonum, Portulaca, Ranunculus, Raphanus, Rorippa, Rotala, Rumex, Salsola, Senecio, Sesbania, Sida, Sinapis, Solanum, Sonchus, Sphenoclea, Stellaria, Taraxacum, Thlaspi, Trifolium, Urtica, Veronica, Viola, Xanthium.

In yet another embodiment, the composition of present disclosure can be used to controls major weeds flora of paddy/rice crop includes:Cynodondactylon, Dactylocteniumaegyptium, Digitariaciliaris, Echinochloacolona, Echinochloa crus-galli, Echinochloaglabrescens, Echinochloa crus-pavonis, Echinochloa esculenta, Echinochloafrumentacea, Echinochloa muricata, Echinochloaoryzoides, Echinochloapaludigena Eleusine indica, Imperata cylindrical, Ischaemumrugosum, Leersiahexandra, Leptochloa chinensis, Oryza sativa, Panicum repens, Paspalum distichum, Paspalum scrobiculatum, Rottboelliacochinchinensis, Setaria glauca, Bolboschoenus maritimus, Cyperus difformis, Cyperus haspen, Cyperus iria, Cyperus rotundus, Fimbristylisdichotoma, Fimbristylismiliacea, Scirpusjuncoides, Scirpurroyelei, Aeschynomene aspera, Aeschynomene indica, Ageratum conyzoides, Alternanthera sessilis, Alternanthera philoxeroides, Amaranthus spinosus, Amaranthus viridis, Ammaniabaccifera, Bergia capensis, Commelinabenghalensis, Commelinadiffusa, Cyanotisaxillaris, Eclipta alba, Eclipta prostrate, Eichhornia crassipes, Ipomoea aquatic, Ludwigiaadscendens, Ludwigiahyssopifolia, Ludwigiaoctovalvis, Ludwigia parviflora, Marsilea minuta, Marsilea quadrifoliata, Mimosa diplotricha, Monochoria vaginalis, Pistia stratiotes, Polygonum hydropiper, Portulaca oleracea, Sagittariamilliacea, Sagittariasagittifolia, Sphenocleazeylanica, Trianthemaportulacastrum.

In another embodiment, the ternary composition comprising of pinoxaden may be used to control unwanted vegetation in crop and non crop lands. Examples of the crops on which the present compositions may be applied include GMO (Genetically Modified Organism) and Non GMO traits, hybrids and conventional varieties of soybean (Glycin max), groundnut/Peanut (Arachis hypogaea), green gram (Vigna radiata), black gram (Vigna mungo), chickpea (Cicer aritinum), cowpea (Vigna unguiculata), red gram (Cajanus cajan), french bean (Phaseolus vulgaris), indian bean (Lablab purpureus), horse gram (Macrotyloma uniflorum), field pea (Pisum sativum), cluster bean (Cyamopsis tetragonoloba), lentils (Lens culinaris). Including crops which have been rendered tolerant to herbicides or classes of herbicides (e.g. ALS-, GS-, EPSPS-, PPO-, ACCase- and HPPD-inhibitors) by conventional methods of breeding or by genetic engineering. An example of a crop that has been rendered tolerant to imidazolinones, e.g. imazamox, by conventional methods of breeding is Clearfield® summer rape (canola). Examples of crops that have been rendered tolerant to herbicides by genetic engineering methods include e.g. glyphosate- and glufosinate-resistant maize varieties commercially available under the trade names RoundupReady® and LibertyLink®. which have been rendered resistant to harmful insects by genetic engineering methods, for example Bt cotton (resistant to cotton boll weevil). Crops which are obtained by conventional methods of breeding or genetic engineering and contain so-called output traits (e.g. improved storage stability, higher nutritional value and improved flavour). Other useful plants include turf grass for example in golf-courses, lawns, parks and roadsides, or grown commercially for sod, and ornamental plants such as flowers or bushes.

The composition in accordance with the present invention can be used to control harmful plants that are difficult to control and that sprout from rhizomes, rhizomes or other permanent organs.

The composition in accordance with the present invention can be used to control wide array of weeds in non-cultivated areas, on paths, track systems, industrial areas ("industrial weed control") or the like.

In another embodiment the composition can be used in known plant crops or tolerant crop plants which are still to be developed, are modified by conventional mutagenesis or are genetically modified for any property in comparison to previously occurring plants.

In an embodiment, the composition of the present invention can be used to delay, reduce and/or avoid the onset of herbicidal resistance.

In another embodiment, the composition of the present invention can be used to control unwanted vegetation in plantation crops, orchards, fallow lands, water bodies, field bunds, and the like.

The composition of the present invention may also comprise other active ingredients selected from but not limiting to insecticides, fungicides, pesticides, safeners, fertilizers, growth regulators, and the like and/or combinations thereof. The composition content of these additives is not particularly limiting and may be determined by a skilled technician in the art according to the conventional protocols.

In an embodiment, the composition may further comprise one or more agro- chemically acceptable additives or auxiliary agents. The additives may be selected from dispersing agents, fillers, wetting agents, colorants, adhesives, surfactants, tackifiers, pH regulators, anti-foaming agents, solvents, emulsifier, preservatives, antifreeze agents, penetration agents, fillers, carriers, defoamers, evaporation inhibitors and agents which control the viscosity. solid carriers, combinations thereof and the like.

In an embodiment, the safeners may be selected from safeners include benoxacor, cloquintocet, cloquintocet mexyl, cyprosulfamide, cyometrinil, dicyclonon, dichlormid, dietholate, fenclorim, fenchlorazole, fenchlorazole ethyl, furilazole, fluxofenim, flurazole, isoxadifen, isoxadifen ethyl, mefenpyr, mefenpyr diethyl, mephenate, naphthalic anhydride, oxabetrinil.

In another embodiment, the composition of the present invention may be formulated into formulation including a solid, liquid or semi-solid formulation.

In an embodiment, the formulation may be selected from the group comprising of Capsule suspension (CS), Dispersible concentrate (DC), Emulsifiable concentrate (EC), Emulsion, water in oil (EO), Emulsion, oil in water (EW), Micro-emulsion (ME), Oil dispersion (OD), Oil miscible flowable concentrate (oil miscible suspension (OF), Oil miscible liquid (OL), Suspension concentrate (SC), Suspo-emulsion (SE), Soluble concentrate (SL), Water dispersible granule (WG or WDG), Water soluble granule (SG), Water soluble powder (SP), Wettable powder (WP), A mixed formulation of CS and SC (ZC), A mixed formulation of CS and SE (ZE), A mixed formulation of CS and EW (ZW).

In an embodiment, the excipient used in capsule suspension (CS) formulation may comprise wall forming agent, dispersing agents, wetting agent, wetting-spreading-penetrating agent, solvent, thickener, suspending agent, antifoaming agent, antifreezing agent, preservative, buffering agent.

In another embodiment, the wall forming agent used in capsule suspension (CS) formulation may be selected from the group of first wall forming agent, second wall forming agent, or combinations thereof.

In yet another embodiment, first wall forming agent used in capsule suspension (CS) formulation may be selected from the group comprising Tetramethylene diisocyanate, pentamethylene diisocyanate, hexamethylene diisocyanate, toluene diisocyanate, diphenylmethene-4,4’-diisocyanate, polymethylene polyphenylene isocyanate, 2,4,4’-diphenyl ether tri-isocyanate, 3,3’-dimethyl-4,4’-diphenyl diisocyanate, 3,3’-dimethoxy-4,4’-diphenyl diisocyanate, 1,5-naphthylene diisocyanate and 4,4’4"-triphenylmethane tri-isocyanate, toluene diisocyanate or polymethylenepolyphenylisocyanate, polyurethane comprising of polyfunctional iso cyanate and a polyamine in polarized form, or combinations thereof.

In yet another embodiment, second wall forming agent used in capsule suspension (CS) may be selected from the group comprising Ammonia, hexamine, ethylenediamine, propylene-1,3-diamine, tetramethylenediamine, pentamethylenediamine, 1,6-hexamethylenediamine, diethylenetriamine, triethylenetetramine, tetraethylenepentamine, pentaethylenehexamine, 4,9-dioxadodecane-1, 12-diamine, 1,3- phenylenediamine, 2,4- and 2,6-toluenediamine and 4,4’-diaminodiphenylmethane, 1,3-phenylenediamine, 2,4- and 2,6-toluenediamine, 4,4'-diaminodiphenylmethane, 1,5-diaminonaphthalene, 1,3,5-triaminobenzene, 2,4,6-triaminotoluene, 1,3,6-triaminonaphthalene, 2,4,4'-triaminodiphenyl ether, 3,4,5-triamino-1,2,4-triazole and 1,4,5,8-tetraminoanthraquinone; or combinations thereof.

In yet another embodiment, the dispersing agent used in capsule suspension (CS) may be selected from group comprising Ethoxylated lignosulfonic acid salts, lignosulfonic acid salts, oxidized lignins, lignin salts, salts of styrenemaleic anhydride copolymers, polyvinyl alcohol, salts of partial esters of styrene-maleic anhydride copolymers, partial salts of polyacrylic acid and partial salts of polyacrylic acid terpolymers. the surfactant is lignosulfonate of calcium or sodium or mixtures thereof or a modified kraft lignin with a high sulfonic acid group , dibutylnaphthalenesulfonic acid ,fatty acids, alkyl- and alkylarylsulfonates, alkyl sulfates, lauryl ether sulfates and fatty alcohol sulfates, and salts of sulfated hexa-, hepta- and octadecanols and of fatty alcohol glycol ethers, condensates of sulfonated naphthalene and its derivatives with formaldehyde, condensates of naphthalene or of the naphthalenesulfonic acids with phenol and formaldehyde, polyoxyethyleneoctylphenol ether, ethoxylated isooctyl-, octyl- or nonylphenol, alkyl phenyl polyglycol ethers, tributyl phenyl polyglycol ethers, alkyl aryl polyether alcohols, is tridecyl alcohol, fatty alcohol/ethylene oxide condensates, ethoxylated castor oil, polyoxyethylene alkyl ethers or polyoxypropylene alkyl ethers, lauryl alcohol polyglycol ether acetate, sorbitol esters, lignin-sulphite waste liquors, and proteins, denatured proteins, polysaccharides , ammonium salts of sulfonates, sulfates, phosphates or carboxylates, alkylarylsulfonates, diphenyl sulfonates, alpha-olefin sulfonates, sulfonates of fatty acids and oils, sulfonates of ethoxylated alkylphenols, sulfonates of condensed naphthalene, sulfonates of dodecyl- and tridecyl benzenes, sulfonates of naphthalene and alkylnaphthalenes, sulfosuccinates or sulfosuccinates, alkoxylates, N-alkylated fatty acid amides, amine oxides, esters or sugar-based surfactants, alkylphenols, amines (e.g. tallow amine), amides, aryl phenols, fatty acids or fatty acid esters which have been alkoxylated. Ethylene oxide and/or propylene oxide may be employed for the alkoxylation, preferably ethylene oxide, polyethylene oxide and polypropylene oxide, polyacids or polybases, or combinations thereof.

In another embodiment, the wetting agent used in capsule suspension (CS) formulation may be selected from group comprising Ethylene oxide/propylene oxide block copolymer, Polyarylphenyl ether phosphate, Ethoxylated Fatty Alcohol, Sodium dioctyl sulfosuccinate, sodium lauryl sulphate and sodium dodecyl benzene sulfonate, alkyl diphenylsulfonates, sodium isopropyl naphthalene sulfonate,Alkyl naphthalene sulfonate, Octyl phenol ethoxylate, alkyl phenol ethoxylate, or combinations thereof.

In yet another embodiment, the wetting-spreading-penetrating agent used in capsule suspension (CS) formulation may be selected from group comprising Organosilicone surfactants includes trisiloxane ethoxylate, polydimethylsiloxane, polyoxyethylene methyl polysiloxane, polyoxyalkylene methyl polysiloxane, polyether polymethyl siloxane copolymer, heptamethyl trisiloxane, Polyalkyleneoxide modified heptamethyl trisiloxane, polyether modified polysiloxane, 10 mole ethylene oxide adduct of octylphenol, may or may not be in modified form, may be liquid or powder form, or combinations thereof.

In yet another embodiment, the solvent used in capsule suspension (CS) formulation may be selected from group comprising hydrocarbon solvent such an aliphatic, cyclic and aromatic hydrocarbons (e.g. toluene, xylene, paraffin, tetrahydronaphthalene, alkylated naphthalene or their derivatives, mineral oil fractions of medium to high boiling point (such as kerosene, diesel oil, coal tar oils)); a vegetable oil such as corn oil, rapeseed oil; a fatty acid ester such as C1-C10-alkylester of a C10-C22-fatty acid; or, methyl- or ethyl esters of vegetable oils such as rapeseed oil methyl ester or corn oil methyl ester, acetophenone, 2-Heptanon, 3-heptanone, 2-hexanone, 5-methyl-2-hexanone, 5-methyl-3-heptanone, 3-methyl-2-hexanone, 4-methyl-2-hexanone, 2-methyl-3-hexanone, 4-methyl-3-hexanone, 5-methyl-3-hexanone, 3-ethyl-2-pentanone, 3,3-dimethyl-2-pentanone, 3,4-dimethyl-2-pentanone, 4,4-dimethyl-2-pentanone, 2,2-dimethyl-3-pentanone, 2,4-dimethyl-3-pentanone, 2-octanone , 2,5-dimethyl-3-hexanone, 2,2-dimethyl-3-hexanone, 3,3-dimethyl-2-hexanone, 3,4-dimethyl-2-hexanone, 4,4-dimethyl-3-hexanone, 3-ethyl-4-methyl-2-pentanone, 2-methyl-3-heptanone, 2-methyl-4-heptanone, 3-methyl-2-heptanone, 3-methyl-4-heptanone, 5-methyl-3-heptanone, 6-methyl-2-heptanone, 6-methyl-3-heptanone, 3-octanone, 4-octanone, 2,2,4-trimethyl-3-pentanone, 3-ethyl-3-methyl-2-pentanone, 5-methyl-2-heptanone, isoprene; or combinations thereof.

In yet another embodiment, the thickener used in capsule suspension (CS) formulation may be selected from group comprising Xanthan gum ,Carboxy methyl cellulose, Attapulgite clay, Bentonite clay, or combinations thereof.

In an embodiment, the suspending agent used in capsule suspension (CS) formulation may be selected from group comprising Aluminium Magnesium Silicate, Bentonite clay, Silica, Attapulgite clay, or combinations thereof.

In another embodiment, the antifoaming agent used in capsule suspension (CS) formulation may be selected from group comprising silicone oil, silicone compound, C10~C20 saturated fat acid compounds or C8~C10 aliphatic alcohols compound,Silicone antifoam emulsion, Dimethyl siloxane, Polydimethyl siloxane,Vegetable oil based antifoam, tallow based fatty acids, polyalkyleneoxide modified polydimethylsiloxane, or combinations thereof.

In yet another embodiment, the antifreezing agent used in capsule suspension (CS) formulation may be selected from group comprising ethylene glycol, propane diols, glycerine or the urea,Glycol (Monoethylene glycol, Diethylene glycol, Polypropylene glycol, Polyethylene glycol), Glycerine, Urea, Magnesium sulphateheptahydrate, sodium chloride, or combinations thereof.

In another embodiment, the preservative used in capsule suspension (CS) formulation may be selected from group comprising 1,2-benzisothiazolin-3(2H)-one, sodium salt, Sodium benzoate, 2-bromo-2-nitropropane-1,3-diol, Formaldehyde, Sodium o-phenyl phenate, 5-chloro-2-methyl-4-isothiazolin-3-one & 2-methyl-4-isothiazolin-3-one, or combinations thereof.

In yet another embodiment, the buffering agent used in capsule suspension (CS) formulation may be selected from group comprising Sodium hydroxide,potassium hydroxide,acetic acid,sulphuric acid,hydrochloric acid, ortho phosphoric acid,ammonium hydroxide, or combinations thereof.

In an embodiment, the present disclosure relates to a process of preparing the composition of the present invention or formulation comprising the composition of the present invention.

In an embodiment, the process may comprise the steps of milling, blending, drying, packaging, combinations thereof and the like.

In an embodiment, the excipient used in Emulsifiable concentrate (EC) formulation may comprise solvent, emulsifiers.

In another embodiment, solvent used in Emulsifiable concentrate (EC) formulation may be selected from the group comprising aromatic hydrocarbon is selected from the group comprising of toluene, o-, m-, p-xylene, dodecane, n- decane, n-hexane, benzene, ethylbenzene, isopropylbenzene, tert-butylbenzene, naphthalenes, mono- or polyalkyl-substituted naphthalenes, heavy aromatic naphthalene depleted (Aromatic 200, 100, 150), n-butanol, N-methyl 2-pyrrolidine, methanol, ethanol, n-propanol, isopropanol, n-butanol, tert-butanol, Paraffinic hydrocarbons, cyclohexanone, isophorone and ester solvents such as methyloleate, dimethylamide and morpholineamide derivatives of C6-C16 fatty acids, and mono-alkylene carbonates such as ethylene carbonate, propylene carbonate and butylene carbonates, dimethylsulfoxide (DMSO), 2-ethylhexanol and n-butanol, n-alkylpyrrolidones, fatty acid dimethyl esters, fatty acid esters, dibasic esters, aromatic hydrocarbons and/or aliphatic hydrocarbons, one or more dimethylamides, such as C8-dimethylamide, C10-dimethylamide, C12-dimethylamide, ethylene glycol, propylene glycol, polyalkylene glycols, aromatic hydrocarbons, methylpyrrolidinone (NMP); dimethylformamide (DMF); dimethylisosorbide (DMI); isophorone; acetophenone; 1,3-dimethyl-2-imidazolidonone; lactate esters; dimethyl and diethylcarbonates; alcohols including methanol; ethanol; iso-propanol; n-propanol; n-butanol; iso-butanol; and tert-butanol; Methyl L-lactate, 2-Ethylhexyl L-lactate, Ethyl L-lactate, n-Butyl L-lactate,Octyl phenyl ethoxylates, or combinations thereof.

In yet another embodiment, Emulsifiers used in Emulsifiable concentrate (EC) formulation may be selected from the group comprising salts of dodecylbenzene sulphonate, e.g. Ca-salts or amine salts, and sulphonates of other C11-C16 alkylbenzenes, alkylether sulphates, alkylphenoletherphosphates and ester phosphates; non-ionic surfactants such as alkoxylated alcohols and alkylphenols, ethoxylated fatty acids, ethoxylated vegetable oils, e.g. ethoxylated castor oil, fatty acid esters, e.g. of sorbitol, and their ethoxylated derivatives, ethoxylated amines, and condensates of glycerol; and catanionic emulsifiers such as a cationic amine, optionally in combination with an alkylsulphonate or ether sulphonate or ether phosphate, alkoxylated alcohols; alkoxylated alkylphenols; ethoxylated fatty acids; ethoxylated vegetable oils; ethoxylated tristyrylphenol; fatty acid esters of sorbitol and ethoxylated derivatives thereof; ethoxylated amines and condensates of glycerol; sulfonated alkylbenzenes in the range C11-C16 and salts thereof; alkylether sulphates; alkyletherphosphates; alkylphenoletherphosphates; or combinations thereof; salts of phosphate esters of ethoxylated tristyrylphenol; salts of sulphated ethers of ethoxylated tristyrylphenol; or a catanionic system, wherein a cationic amine is present in combination with an alkylsulphonate, an alkylethersulphonate, an ether sulphate, or an ether phosphate such as an alkyletherphosphate, nonylphenol polyethoxyethanols, castor oil polyglycol ethers, polyadducts of ethylene oxide and polypropylene, tributyl phenoxy polyethoxy ethanol, octyl phenoxy polyethoxy ethanol.

In yet another embodiment, Sticker, surface tension reducer, binder used in Emulsifiable concentrate (EC) formulation may be selected from Polyvinylpyrrolidone.

In yet another embodiment, Spreader, sticker, penetrant, surface tension reducer used in Emulsifiable concentrate (EC) formulation may be selected from Alkyl polyethylene glycol ether.

In an embodiment, the excipient used in Micro Emulsion (ME) formulation may comprise Green solvent, Solvent, Dispersing agent cum emulsifier.

In another embodiment, Green solvent used in Micro Emulsion (ME) formulation may be selected from N,N-Dimethyldecanamide.

In yet another embodiment, solvent used in Micro Emulsion (ME) formulation may be selected from N-Methylpyrrolidone, Cyclohexane, or combinations thereof.

In another embodiment, Dispersing agent cum emulsifier used in Micro Emulsion (ME) formulation may be selected from Ethoxylated TristyrylPhenol.

In yet another embodiment, Dispersing agent cum emulsifier cum wetting agent used in Micro Emulsion (ME) formulation may be selected from Polyalkoxylated butyl ether.

In another embodiment, Anti freezing agent used in Micro Emulsion (ME) formulation may be selected from Glycols.

In yet another embodiment, Antifoam used in Micro Emulsion (ME) formulation may be selected from Silicone antifoam emulsion.

In another embodiment, Spreading cum wetting agent used in Micro Emulsion (ME) formulation may be selected from Trisiloxane ethoxylate.

In yet another embodiment, Preservative/biocides used in Micro Emulsion (ME) formulation may be selected from the group of sodium benzoate, 2-bromo-2-nitropropane-1,3-dion, formaldehyde, or combinations thereof.

In an embodiment, the excipient used in Oil dispersion (OD) formulation may comprise super wetting-spreading-penetrating agent, solvent, dispersing agents, emulsifier, Stabilizers, Antifoaming agent, Anti-freezing agent, Preservative, Buffering agent, Polar Co-solvent.
In another embodiment, the Super Wetting-spreading-penetrating agent used in Oil dispersion (OD) formulation may be selected from the group of Polyalkyleneoxide modified Heptamethyltrisiloxane (Modified trisiloxane).

In yet another embodiment, the solvent used in Oil dispersion (OD) formulation may be selected from the group of pongamia/karanja/karanj (Millettia pinnata/Pongamia pinnata/Pongamia glabra) oil, palm (Elaeis spp.) oil (Palm kernel oil), mahua (Madhuca longifolia) oil, jojoba (Simmondsia chinensis), blend of pongamiaoil and palm oil, blend of pongamia oil and mahua oil, blend of pongamia oil and jojoba (Simmondsia chinensis), blend of pongamia oil and vegetable oil, blend of palm oil and mahua oil, blend of palm oil and jojoba oil, blend of palm oil and vegetable oil, blend of pongamia oil, palm oil and mahua oil blend of pongamia oil, palm oil and jojoba oil, blend of pongamia oil, palm oil and vegetable oil, the vegetable oil may be any one or mixture of two or more selected from soybean (Glycine max) oil, groundnut (Arachis hypogaea) oil, rapeseed (Brassica napus subspecies) oil, mustard (Brassica juncea) oil, sesame (Sesamum indicum) oil, corn (Zea mays) oil, rice (Oryza sativa) bran oil, castor (Ricinum communis) seed oil, cotton (Gossypiumhirsutum) seed oil, linseed (Linumusitatissimum), coconut (Cocos nucifera) oil, sunflower (Helianthus annuus) oil, safflower (Carthamus tinctorius) seed oil. As solvent for the present formulation, the pongamia oil, palm oil, mahua oil, jojoba oil, vegetable oil and their mixtures may be alkylated or ethoxylated or epoxylated or esterified. Examples methyl ester of pongamiaoil, methyl ester of palm oil, methyl ester of pongamial oil and palm oil, methyl ester of pongamia oil and mahua oil, methyl ester of pongamia oil and jojoba oil, methyl ester of pongamia oil and vegetable oil, methyl ester of palm oil and mahua oil, methyl ester of palm oil and jojoba oil, methyl ester of palm oil and vegetable oil, methyl ester of pongamiaoil+palmoil+vegetable oil, or combinations therof.

In another embodiment, the Emulsifier used in Oil dispersion (OD) formulation may be selected from the group of castor oil ethoxylates, alcohol ethoxylates, fatty acid ethoxylates, sorbitan ester ethoxylates, sulphosuccinate, calcium salts of dodecylbenzene sulphonate, alkylammonium salts of alkylbenzene sulphonate, alkylsulphosuccinate salts, ethylene oxide-propylene oxide block copolymers, ethoxylated alkylamines, octylphenol ethoxylate, ethoxylated alkyl phenols, ethoxylated sorbitol oleates, polyoxyethylenesorbitan monolaurate, or combinations thereof.

In yet another embodiment, the dispersing agent used in Oil dispersion (OD) formulation may be selected from the group of condensed naphthalene sulfonate, Propoxylated Ethoxylated copolymer monoalkylether (ethylhexanol), alkyl sulfonates, alkyl benzene sulfonates, alkyl aryl sulfonates, alkylphenolalkoxylates, tristyrylphenol ethoxylates, natural or synthetic fatty ethoxylate alcohols, natural or synthetic fatty acid alkoxylates, natural or synthetic fatty alcohols alkoxylates, alkoxylated alcohols (such as n-butyl alcohol poly glycol ether), block copolymers (such as ethylene oxide-propylene oxide block copolymers and ethylene oxide-butylene oxide block copolymers), fatty acid-polyalkylene glycol condensates, polyamine-fatty acid condensates, polyester condensates, salts of polyolefin condensates, sodium ligno sulfonate, sodium polycarboxylate, EO/PO based copolymer, phenol sulfonate, sodium methyl oleoyl taurate, styrene acrylic acid copolymer, propyleneoxide-ethyleneoxide-copolymer, polyethylene glycol 2,4,6-tristyrylphenyl ether, tristyrylphenol-polyglycolether-phosphate, tristyrylphenole with 16 moles EO, tristyrylphenol-polyglycolether-phosphate, oleyl-polyglycolether with ethylene oxide, tallow fattyamine polyethylene oxide, nonylphenol polyglycolether with 9-10 moles ethylene oxide, or combinations thereof.

In another embodiment, the Stabilizers used in Oil dispersion (OD) formulation may be selected from the group of hectorite clay, aluminium magnesium silicate, bentonite clay, silica, attapulgite clay or combinations thereof.

In another embodiment, the Antifoaming agent used in Oil dispersion (OD) formulation may be selected from the group of silicone oil, silicone compound, C10~C20 saturated fat acid compounds or C8~C10 aliphatic alcohols compound, silicone antifoam emulsion, dimethylsiloxane, polydimethyl siloxane, or combinations thereof.

In yet another embodiment, the Anti-freezing agent used in Oil dispersion (OD) formulation may be selected from the group of ethylene glycol, propane diols, glycerine or the urea, glycol (Monoethylene glycol, Diethylene glycol, Polypropylene glycol, Polyethylene glycol), glycerine, urea, magnesium sulfate heptahydrate, sodium chloride, or combinations thereof.

In another embodiment, the Preservative agent used in Oil dispersion (OD) formulation may be selected from the group of 1,2-benzisothiazolin-3(2H)-one, sodium salt, sodium benzoate, 2-bromo-2-nitropropane-1,3-diol, formaldehyde, sodium o-phenylphenate, 5-chloro-2-methyl-4-isothiazolin-3-one & 2-methyl-4-isothiazolin-3-one, Butyl hydroxyl toluene, or combinations thereof.

In another embodiment, the buffering agent used in Oil dispersion (OD) formulation may be selected from the group of Citric acid, sodium carbonate, sodium bicarbonate, sulphuric acid, hydrochloric acid, sodium hydroxide, potassium hydroxide, acetic acid, sorbic acid, or combinations thereof.

In yet another embodiment, optionally the polar cosolvent used in Oil dispersion (OD) formulation may be selected from the group of cyclohexanone, acetophenone, butanol, n-octanol, n-propanol, 1-hexanol, propylene carbonate, n-methyl-2-pyrrolidone, or combinations thereof.

In an embodiment, the present invention relates to a process of preparing the Oil dispersion (OD) formulation comprising the steps:

Step 1- Charge the oil (pongamia oil or palm oil or pongamia oil + palm oil or pongamia oil + mahua oil, pongamia oil + jojoba oil or pongamia oil + vegetable oil or palm oil + mahua oil or palm oil + jojoba oil or palm oil + vegetable oil or pongamia oil + palm oil + vegetable oil) or solvent or both into a vessel with anchor stirrer.

Step 2-Under stirring, add the emulsifier/superwetting-spreading-penetrating agent(Polyalkyleneoxide modified Heptamethyl trisiloxane)and dispersing agent and stir until all ingredients are dissolved completely.

Part B-Preparation of the slurry
Step 1- Now, charge the liquid premix into a second vessel, equipped with a cooling and heating device and a high shear stirrer.

Step 2- Add the active ingredient(s) and homogenize thoroughly. Pre-mill this mixture and finally mill it using a bead mill/sand mill/attritor to achieve a particle size distribution as required by the specification.

Part C-Preparation of the Thickener gel
Step 1- Charge the remaining oil or solvent to the vessel, equipped with a high shear stirrer.

Step 2- Add gradually the thickening agent, maintaining high-shear mixing throughout. Stirring is continued until thoroughly mixed.

Step 3- Under stirring, the thickener is added. Allow the gel to swell whilst maintaining mixing.

Part D-Preparation of the final formulation
Step 1- Now add the thickener gel solution into milled slurry and disperse the mixture by using a high shear stirrer.

Step 3- Check the finished formulation to specification.

Step 4- After approval, material is packed in required pack sizes.

In an embodiment, the excipient used in Suspension Concentrate (SC) formulation may comprise Wetting agent, Dispersing agent, Suspending agent, Antifoaming agent, Anti-freezing agent, Preservatives, Thickeners-, Humectant.

In another embodiment, the Wetting agent used in Suspension Concentrate (SC) formulation may be selected from the group of ethylene oxide/propylene oxide block copolymer, polyarylphenyl ether phosphate, polyalkoxylated butyl ether, ethoxylated fatty alcohol, sodium dioctyl sulfosuccinate, sodium lauryl sulfate and sodium dodecyl benzene sulfonate, alkyl diphenyl sulfonates, sodium isopropyl naphthalene sulfonate, alkyl naphthalene sulfonate, organosilicons surfactants (as a wetting-spreading-penetrating agent) includes trisiloxane ethoxylate, polydimethylsiloxane,polyoxyethylene methyl polysiloxane,polyoxyalkylene methyl polysiloxane,polyether polymethyl siloxane copolymer,heptamethyl trisiloxane, modified form includes polyalkyleneoxide modified heptamethyl trisiloxane,polyether modified polysiloxane, polyalkyleneoxide modified trisiloxane, polyalkyleneoxide modified polydimethylsiloxane, trisiloxane ethoxylate, polyoxyethylene methyl polysiloxane, polyether polymethyl siloxane copolymer, polyether modified polysiloxane; may or may not be in modified form, may be liquid or powder form, or combinations thereof.

In yet another embodiment, the Dispersing agent used in Suspension Concentrate (SC) formulation may be selected from the group of Naphthalenesulfonic acid, sodium salt condensated with formaldehyde, alkylated naphthalene sulfonate, sodium salt, sodium salt of naphthalene sulfonate condensate, sodium ligno sulfonate, sodium polycarboxylate, EO/PO based copolymer, phenol sulfonate, sodium methyl oleoyl taurate, styrene acrylic acid copolymer, propylene oxide-ethylene oxide-copolymer, polyethylene glycol 2,4,6-tristyrylphenyl ether, tristyrylphenol-polyglycol ether-phosphate, tristyrylphenole with 16 moles EO, tristyrylphenol-polyglycol ether-phosphate, oleyl-polyglycol ether with ethylene oxide, tallow fatty amine polyethylene oxide, nonylphenol polyglycol ether with 9-10 moles ethylene oxide, or combinations thereof.

In another embodiment, the Suspending agent used in Suspension Concentrate (SC) formulation may be selected from the group of aluminum magnesium silicate, bentonite clay, silica, attapulgite clay, or combinations thereof.

In another embodiment, the Antifoaming agent used in Suspension Concentrate (SC) formulation may be selected from the group of silicone oil, silicone compound, C10~C20 saturated fat acid compounds or C8~C10 aliphatic alcohols compound, silicone antifoam emulsion, dimethyl siloxane, polydimethyl siloxane, vegetable oil based antifoam, tallow based fatty acids, polyalkyleneoxide modified polydimethylsiloxane, or combinations thereof.

In yet another embodiment, the Anti-freezing agent used in Suspension Concentrate (SC) formulation may be selected from the group of ethylene glycol, propane diols, glycerin or the urea, glycol (monoethylene glycol, diethylene glycol, polypropylene glycol, polyethylene glycol), glycerin, urea, magnesium sulfate heptahydrate, sodium chloride, or combinations thereof.

In another embodiment, the Preservatives used in Suspension Concentrate (SC) formulation may be selected from the group of 1,2-benzisothiazolin-3(2H)-one, sodium salt, sodium benzoate, 2-bromo-2-nitropropane-1,3-diol, formaldehyde, sodium o-phenyl phenate, 5-chloro-2-methyl-4-isothiazolin-3-one & 2-methyl-4-isothiazolin-3-one, or combinations thereof.

In another embodiment, the thickeners used in Suspension Concentrate (SC) formulation may be selected from the group of xanthan gum, PVK, carboxymethyl celluloses, polyvinyl alcohols, gelatin, sodium carboxymethylcellulose, hydroxyethyl cellulose, sodium polyacrylate, modified starch, acacia gum, or combinations thereof.

In yet another embodiment, the humectant used in Suspension Concentrate (SC) formulation may be selected from the group of urea, humic acid, glycerol, lactose, or combinations thereof.

In an embodiment, the present invention relates to a process of preparing the Suspension Concentrate (SC) formulation comprising the steps:

Step 1- 2% Gel Preparation:
Charge the required quantity of water to a vessel, equipped with a high shear stirrer and start the agitation. Add the required amount of preservative. Mix until homogenous. Add the required amount of thickener and mix vigorously until it is fully wetted.

Step 2- Charge the required quantity of water to a vessel, equipped with bulk agitator and a high shear homogenizer and start agitation. Add the required amount of ant freezing agent and mix until uniform. Add the antifoaming agent and ensure that it is well dispersed. Add the wetting and dispersing agent and mix until uniform. Ensure that the dispersing agent is fully dispersed.

Step 3- Now add the active ingredient and continue agitating the vessel contents until all components get dissolved. Mill this pre-mix through a Colloid mill and subsequently through a Dyno mill to meet the specified particle size.

Step 4- Now add remaining antifoaming agent to this SC mill base to a vessel, equipped with bulk agitator. Mix until uniform. Add the required amount of 2% aqueous pre-gel and suspending agent and continue agitation until the formulation is homogeneous and has the target viscosity is reached.

Step 5- Final product is sent for QC approval.

Step 6- After approval, material is packed in required pack sizes.

In an embodiment, the excipient used in Suspo Emulsion (SE) formulation may comprise Solvent, Emulsifier, Stabilizer, Anti-freezing agent, Antifoaming agent, Suspending agent, Wetting agent, Wetting-spreading-penetrating agent, Preservatives, Thickeners, Dispersing agent, Buffering agent, Humectant.

In another embodiment, the solvent used in Suspo Emulsion (SE) formulation may be selected from the group of water, water soluble alcohols and dihydroxy alcohol ethers. Water soluble alcohol or lower alcohol (1-4 carbon atoms) includes-methanol, ethanol, n-propanol, isopropanol, n-butanol, tert-butanol. Macromolecular alcohol includes polyethylene glycol, sorbitol, glucitol etc., dihydroxy alcohol ethers includes dihydroxy alcohol alkyl ether or dihydroxy alcohol aryl ethers. The examples of dihydroxy alcohol alkyl ether include ethylene glycol methyl ether, diethylene glycol methyl ether, propylene glycol methyl ether, di-propylene glycol methyl ether, ethylene glycol ethyl ether, diethylene glycol ethyl ether, propylene glycol ethyl ether, di-propylene glycol ethyl ether, etc. The examples of dihydroxy alcohol aryl ethers include ethylene glycol phenyl ether, 5 diethylene glycol phenyl ether, propylene glycol phenyl ether, di-propylene glycolphenyl ether, Hyrdocarbons includes n-pentane, hexane(s), cyclohexane, methylcyclohexane, heptane, isooctane, benzene, toluene, xylene(s), isophorone and ester solvents such as methyloleate, dimethylamide and morpholineamide derivatives of C6-C16 fatty acids, and mono-alkylene carbonates such as ethylene carbonate, propylene carbonate and butylene carbonates, dimethylsulfoxide (DMSO), 2-ethylhexanol and n-butanol, n-alkylpyrrolidones, fatty acid dimethyl esters, fatty acid esters, dibasic esters, aromatic hydrocarbons and/or aliphatic hydrocarbons, one or more dimethylamides, such as C8-dimethylamide, C10-dimethylamide, C12-dimethylamide, ethylene glycol, propylene glycol, polyalkylene glycols, aromatic hydrocarbons, methylpyrrolidinone (NMP); dimethylformamide (DMF); dimethylisosorbide (DMI); isophorone; acetophenone; 1,3-dimethyl-2-imidazolidonone; lactate esters; dimethyl and diethylcarbonates; alcohols including methanol; ethanol; iso-propanol; n-propanol; n-butanol; iso-butanol; and tert-butanol; Methyl L-lactate, 2-Ethylhexyl L-lactate, Ethyl L-lactate, n-Butyl L-lactate,Octyl phenol ethoxylates; or combinations thereof.

In yet another embodiment, the emulsifiers used in Suspo Emulsion (SE) formulation may be selected from the group of salts of dodecylbenzene sulphonate, e.g. Ca-salts or amine salts, and sulphonates of other C11-C16 alkylbenzenes, alkylether sulphates, alkylphenoletherphosphates and ester phosphates; non-ionic surfactants such as alkoxylated alcohols and alkylphenols, ethoxylated fatty acids, ethoxylated vegetable oils, e.g. ethoxylated castor oil, fatty acid esters, e.g. of sorbitol, and their ethoxylated derivatives, ethoxylated amines, and condensates of glycerol; and catanionic emulsifiers such as a cationic amine, optionally in combination with an alkylsulphonate or ether sulphonate or ether phosphate, alkoxylated alcohols; alkoxylated alkylphenols; ethoxylated fatty acids; ethoxylated vegetable oils; ethoxylated tristyrylphenol (tristyrlphenol with 16 moles EO), tristyrylphenol-polyglycolether-phosphate, fatty acid esters of sorbitol and ethoxylated derivatives thereof; ethoxylated amines and condensates of glycerol; sulfonated alkylbenzenes in the range C11-C16 and salts thereof; alkylether sulphates; alkyletherphosphates; alkylphenoletherphosphates; or combinations thereof; salts of phosphate esters of ethoxylated tristyrylphenol; salts of sulphated ethers of ethoxylated tristyrylphenol; or a catanionic system, wherein a cationic amine is present in combination with an alkylsulphonate, an alkylethersulphonate, an ether sulphate, or an ether phosphate such as an alkyletherphosphate, nonylphenol polyethoxyethanols, castor oil polyglycol ethers, polyadducts of ethylene oxide and polypropylene, tributyl phenoxy polyethoxy ethanol, octyl phenoxy polyethoxy ethanol, or combinations thereof.

In another embodiment, the stabilizer used in Suspo Emulsion (SE) formulation may be selected from the group of butylated hydroxytoluene (BHT) and epoxidized soybean oil (ESBO), Epichlorhydrin, or combinations thereof.

In yet another embodiment, the anti-freezing agent used in Suspo Emulsion (SE) formulation may be selected from the group of ethylene glycol, propane diols, glycerine or the urea, glycol (monoethylene glycol, diethylene glycol, polypropylene glycol, polyethylene glycol), glycerine, urea, magnesium sulfate heptahydrate, sodium chloride, or combinations thereof.

In another embodiment, the antifoaming agent used in Suspo Emulsion (SE) formulation may be selected from the group of silicone oil, silicone compound, C10~C20 saturated fat acid compounds or C8~C10 aliphatic alcohols compound, silicone antifoam emulsion, dimethylsiloxane, polydimethyl siloxane, vegetable oil based antifoam, tallow based fatty acids, polyalkyleneoxide modified polydimethylsiloxane, or combinations thereof.

In yet another embodiment, the suspending agent used in Suspo Emulsion (SE) formulation may be selected from the group of aluminium magnesium silicate, bentonite clay, silica, silicone dioxide, attapulgite clay, or combinations thereof.

In another embodiment, the wetting agent used in Suspo Emulsion (SE) formulation may be selected from the group of Ethylene oxide/propylene oxide block copolymer, Polyarylphenyl ether phosphate, Ethoxylated Fatty Alcohol, Sodium dioctyl sulfosuccinate, sodium lauryl sulphate and sodium dodecyl benzene sulfonate, alkyl diphenylsulfonates, sodium isopropyl naphthalene sulfonate, Alkyl naphthalene sulfonate, Octyl phenol ethoxylate, alkyl phenol ethoxylate, combinations thereof.

In yet another embodiment, the wetting-spreading-penetrating agent used in Suspo Emulsion (SE) formulation may be selected from the group of Organosilicone surfactants includes trisiloxane ethoxylate, polydimethylsiloxane, polyoxyethylene methyl polysiloxane, polyoxyalkylene methyl polysiloxane, polyether polymethyl siloxane copolymer, heptamethyl trisiloxane, Polyalkyleneoxide modified heptamethyl trisiloxane, heptamethyl trisiloxane ethoxylate, polyether modified polysiloxane, 10 mole ethylene oxide adduct of octylphenol, may or may not be in modified form, may be liquid or powder form or combinations thereof.

In another embodiment, the preservatives used in Suspo Emulsion (SE) formulation may be selected from the group of propionic acid and its sodium salt, sorbic acid and its sodium or potassium salt, benzoic acid and its sodium salt, p-hydroxy benzoic acid sodium salt; methyl p-hydroxy benzoate; and biocide such as sodium benzoate, 1,2-benzisothiazoline-3-one, 2-methyl-4-isothiazolin-3-one, 5-chloro-2- methyl-4-isothiazolin-3-one, potassium sorbate, parahydroxy benzoates, or combinations thereof.

In another embodiment, the thickeners used in Suspo Emulsion (SE) formulation may be selected from the group of thickening, gelling, and anti-settling agents generally fall into two categories, namely water-insoluble particulates and water-soluble polymers. It is possible to produce suspension concentrate formulations using clays and silicas. Examples of these types of materials, include, but are limited to, montmorillonite, e.g. bentonite; magnesium aluminum silicate; and attapulgite. Water-soluble polysaccharides have been used as thickening-gelling agents for many years. The types of polysaccharides most commonly used are natural extracts of seeds and 15 seaweeds are synthetic derivatives of cellulose or mixtures thereof. Examples of these types of materials include, but are not limited to, guar gum; locust bean gum; carrageenam; xanthan gum; alginates; methyl cellulose; sodium carboxymethyl cellulose (SCMC); hydroxyethyl cellulose (HEC) or mixtures thereof. Other types of anti-settling agents are based on modified starches, polyacrylates, polyvinyl 20 alcohol and polyethylene oxide, or combinations thereof.

In yet another embodiment, the dispersing agent used in Suspo Emulsion (SE) formulation may be selected from the group of polyesters, polyamides, poly- carbonates, polyurea and polyurethanes,acrylic polymers, acrylic graft copolymer, styrene copolymers, butadiene copolymers, polysaccharides such as starch and cellulose derivatives, vinylalcohol, vinylacetate and vinylpyrrolidone polymers and copolymers, polyethers, epoxy, phenolic and melamine resins, polyolefins and define copolymers and mixtures thereof. Examples of preferred polymers are acrylate polymers such as poly(methacrylate), poly(ethyl methacrylate), poly(methylmethacrylate), acrylate copoylmers and styrene-acrylic copolymers as defined herein below, poly(styrene-co maleic anhydride), cellulosic polymers such as ethyl cellulose, cellulose acetate, cellulose acetatebutyrate, acetylated mono, di, and triglycerides, poly(vinylpyrrolidone), vinyl acetate polymers and copolymers, poly(alkylene glycol), styrene butadiene copolymers, poly(orthoesters), alkyd resins, and mixtures of two or more of these. Polymers that are biodegradable are also useful in the present invention. As used herein, a polymer is biodegradable if is not water soluble, but is degraded over a period of several weeks when placed in an application environment. Examples of biodegradable polymers that are useful in the present invention include biodegradable polyesters, starch, polylactic acid starch blends, polylactic acid, poly(lactic acid-glycolic acid) copolymers, polydioxanone, cellulose esters, ethyl cellulose, cellulose acetate butyrate, starch esters, starch esteraliphatic polyester blends, modified corn starch, polycaprolactone, poly(namylmethacrylate), wood rosin, polyanhydrides, polyvinylalcohol, polyhydroxybutyratevalerate, biodegradable aliphatic polyesters, and polyhydroxybutyrate or mixtures thereof.The examples of dispersing agents are alkylated naphthalene sulfonate, sodium salt, sodium salt of naphthalene sulfonate condensate, sodium salt of alkyl naphthalene sulfonate, sodium ligno sulfonate, sodium ploycarboxylate,EO/PO block copolymer, phenol sulfonate, sodium methyl oleoyl taurate, styrene acrylic acid copolymer, propyleneoxide-ethyleneoxide-copolymer, polyethylene glycol 2,4,6-tristyrylphenyl ether, tristyrylphenol-polyglycolether-phosphate, tristyrylphenole with 16 moles EO, tristyrylphenol-polyglycolether-phosphate, oleyl-polyglycolether with ethylene oxide, tallow fattyamine polyethylene oxide, nonylphenol polyglycolether with 9-10 moles ethylene oxide, or combinations thereof.

In yet another embodiment, the Buffering agent used in Suspo Emulsion (SE) formulation may be selected from the group of calcium hydroxyapatite, Potassium Dihydrogen Phosphate, Sodium Hydroxide, carbonated apatite, calcium carbonate, sodium bicarbonate, tricalcium phosphate, calcium phosphates, carbonated calcium phosphates, amine monomers, lactate dehydrogenase and magnesium hydroxide, or combinations thereof.

In another embodiment, the Humectant used in Suspo Emulsion (SE) formulation may be selected from the group of urea, humic acid, glycerol, lactose.

In an embodiment, the present invention relates to a process of preparing the Suspo Emulsion (SE) formulation comprising the steps:

Step 1- 2% Gel Preparation: Charge the required quantity of water to a vessel, equipped with a high shear stirrer and start the agitation. Add the required amount of preservative. Mix until homogenous. Add the required amount of thickener and mix vigorously until it is fully wetted.

Step 2- Oil Phase : Charge solvent into the vessel and then add active technical slowly and if required, heat it for 500C so that technical can be dissolved in solvent and then add emulsifier.

Step 3-Charge the required quantity of water to a vessel, equipped with bulk agitator and a high shear homogenizer and start agitation. Add the required amount of ant freezing agent and mix until uniform. Add the antifoaming agent and ensure that it is well dispersed. Add the wetting and dispersing agent and mix until uniform. Ensure that the dispersing agent is fully dispersed.

Step 4-Now add the active ingredient and continue agitating the vessel contents until all components get dissolved. Mill this pre-mix through a Colloid mill and subsequently through a Dyno mill to meet the specified particle size.

Step 5-Now add remaining antifoaming agent to this mill base to a vessel, equipped with bulk agitator. Mix until uniform.

Step 6-Now add oil phase in aqueous phase and stir for 30 minutes using homogenizer.

Step 7-Add the required amount of 2% aqueous pre-gel and also suspending agent and continue agitation until the formulation is homogeneous and has the target viscosity. Mix well.

Step 8-Final product is sent for QC approval.

Step 9-After approval, material is packed in required pack sizes.

In an embodiment, the excipient used in Wettable Granule (WG) formulation may comprise Dispersing agents, Wetting agents, Antifoaming agent, Carrier, Humectant.

In yet another embodiment, the dispersing agents used in Wettable Granule (WG) formulation may be selected from the group of sodium polycarboxylate (sodium polyacrylate), naphthalenesulfonic acid, sodium salt condensates with formaldehyde, polyalcoxylated alkylphenol, naphthalenesulfonic acid formaldehyde condensate, methylnaphthalene-formaldehyde-condensate sodium salt, naphthalene condensates, lignosulfonates, calcium lignosulfonate,lignin sulfonate sodium salt, alkyl naphthalene sulfonate, sodium salt. The preferred dispersing agent is alkyl naphthalene sulfonate. It provides an excellent wetting, dispersing, hydrotroping and medium to low foaming. It offers acid and base stability, hard water tolerance and high temperature stability.

In another embodiment, the wetting agents used in Wettable Granule (WG) formulation may be selected from the group of sodium N-methyl-N-oleoyl taurate, alkylated naphthalene sulfonate, sodium salt, mixture of isomers of dibutylnaphthalene sulphonic acid sodium salt, sodium di-isopropylnaphthalenesulphonate, sodium Lauryl sulfate, dioctyl sulfate, alkyl naphthalene sulfonates, phosphate esters, sulphosuccinates and non-ionic such as tridecyl alcohol ethoxylate, alkyl or alkaryl sulfonates such as alkylbenzene sulfonates, alpha olefin sulfonate and alkyl naphthalene sulfonates, ethoxylated or non-ethoxylated alkyl or alkaryl carboxylates, alkyl or alkaryl phosphate esters, alkyl polysaccharide, di or mono alkyl sulfosuccinate derivatives, alpha olefin sulfonates, alkyl naphthalene sulfonates, dialkyl sulphosuccinates, butyl, dibutyl, isopropyl and di-isopropyl naphthalene sulfonate salts, C12 alkyl benzene sulfonate or C10-C16 alkyl benzene sulfonate, organosilicons surfactants includes trisiloxane ethoxylate, polydimethylsiloxane, polyoxyethylene methyl polysiloxane, polyoxyalkylene methyl polysiloxane, polyether polymethyl siloxane copolymer, trisiloxane heptamethyl, Polyalkyleneoxide modified heptamethyl trisiloxane, polyether modified polysiloxane, may or may not be in modified form, may be liquid or powder form, or combination thereof.

In another embodiment, the antifoaming agent used in Wettable Granule (WG) formulation may be selected from polydimethylsiloxane.

In yet another embodiment, the carrier used in Wettable Granule (WG) formulation may be selected from china clay, silica, lactose anhydrous, ammonium sulfate, sodium sulfate anhydrous, corn starch, urea, EDTA, urea formaldehyde resin, diatomaceous earth, kaolin, bentonite, kieselguhr, fuller's earth, attapulgite clay, bole, loess, talc, chalk, dolomite, limestone, lime, calcium carbonate, powdered magnesia, magnesium oxide, magnesium sulphate, sodium chloride, gypsum, calcium sulphate, pyrophyllite, silicates and silica gels; fertilizers such as, for example, ammonium sulphate, ammonium phosphate, ammonium nitrate and urea; natural products of vegetable origin such as, for example, grain meals and flours, bark meals, wood meals, nutshell meals and cellulosic powders; and synthetic polymeric materials such as, for example, ground or powdered plastics and resins, bentonites, zeolites, titanium dioxide, iron oxides and hydroxides, aluminium oxides and hydroxides, or organic materials such as bagasse, charcoal, or synthetic organic polymers, or combinations thereof.

In yet another embodiment, the Humectant used in Wettable Granule (WG) formulation may be selected from humic acid, glycerol, lactose, Sodium sulphate anhydrous, or combinations thereof.

In an embodiment, the present invention relates to a process of preparing the capsule suspension (cs) formulation comprising the steps:

Step 1-Aqueous Phase-Charge water to a stainless-steel vessel equipped with a high speed stirrer. Under agitation, add the wetting agent, dispersing agent 1and dispersing agent 2 into the vessel. NoECw add 50% quantity of antifoam to avoid foam generation in this vessel.

Step 2-Organic Phase-Charge heavy aromatic hydrocarbons solvent into second stainless-steel reactor. Then, slowly add melted active ingredient into the reactor. Afterwards, charge wall forming material 1 material to the reactor. Continue mixing. Cool the reactor contents to room temperature.

Step 3-Start the high shear disperser of aqueous phase and charge the ‘Organic Solution’ into the ‘Aqueous Phase Solution’ under gravity in specific rate so that required particle size can be achieved and continue to shear for 30 min. Then, start heating the reactor to around 50 °C and stir the formulation under slow rpm for 3-4 hours so that Polymerization reaction gets completed.

Step 4-Now add wall forming material 2 so that residual wall forming material 1 can be consumed and stir for 1 more hour at the same temperature and if required add half quantity of antifoam to remove foam generating due to CO2 during reaction.

Step 5-After the wall polymerization reaction, increase the agitator to high speed. Add the rest half quantity of antifoam to the formulation. Under slight vacuum, allow the mixture to de-gas for approximately 30 minutes to remove CO2 from the solution. Add the linear polysaccharide, preservative and in last freezing agent and mix for some minutes. Add buffering agent for pH adjustment and mix well.

Step 6-Final product is sent for QC approval.

Step 7-After approval, material is packed in required pack sizes.

In another embodiment, the present disclosure relates to a method of controlling growth of undesired plants by application of a herbicidally effective amount of an composition of the present invention or formulation comprising the same.

In still another embodiment, the present disclosure relates to a method of preventing undesired plants from infecting crops by applying a herbicidally effective amount of the composition of the present invention or formulation comprising the same.

In yet another embodiment, the present disclosure relates to use of the composition of the present invention or formulation comprising the same on unwanted vegetation or plants.
In an embodiment the formulation of present invention may be present in the commercial form for example wettable powders, emulsifiable concentrates, dispersions and water-dispersible granules using water for use are optionally diluted in the customary manner with water or other inert substance before use. The manner of use can include mixing the formulation together with water in the tank and the spray mixture, application before or after sowing, apply to the open furrow in which the seeds have been sown, seed dressing or treatment of the germinated seedlings.

In an embodiment the composition of the present invention as such or formulation comprising the same can be applied to the plants (for example harmful plants such as mono- or dicotyledon weeds or undesired crop plants), the seeds (for example grains, seeds or vegetative propagation organs such as tubers or shoot parts with buds) or the area on which the plants grow (for example the area under cultivation).

In an embodiment the composition of the present invention as such or formulation comprising the same can be applied in the pre-sowing (possibly also by incorporation into the soil), pre-emergence or post-emergence methods. Preference is given to use in the early post-sowing pre-emergence process or in the post-emergence process of plantation crops against harmful plants which have not yet emerged or have already emerged. The application can also be integrated into weed management systems, with shared multiple applications for example sequential applications.

In an embodiment, the composition or formulation in accordance with the present disclosure may be applied via tank mix method or sequential application. The composition may be used pre-emergence or post-emergence of undesired plants. It may be applied on the locus of the plant, including all plant parts, or on the soil or turf of growth. It may be applied before or after the crop seeds are planted.

In an embodiment, the composition lowers the application rate of active compounds on the undesired plants based on the formulation the way of application may be selected from spraying, dusting, scattering, soaking and the like.

In an embodiment, the composition or formulation comprising the same slows down the growth or kills the undesired plants. The herbicide compounds comprised in the composition in synergistic manner intervene the undesired plant's own metabolism and can thus be used to influence plant constituents in a targeted manner and to facilitate the harvest, e.g. by triggering desiccation and stunted growth. Furthermore, they are also suitable for general control and inhibition of undesirable vegetative growth without killing the plants, which can play an important role in many monocotyledonous and dicotyledon crops, as this can reduce or completely prevent storage.

The synergistic pesticide action of the inventive mixtures are demonstrated by the examples below. A synergistic effect exists wherever the action of a combination (ready-mix) or tank mix of active ingredient is greater than the sum of the action of each of the components alone. Therefore, a synergistically effective amount or an effective amount of a synergistic composition or combination is an amount that exhibits greater pesticide activity than the sum of the pesticide activities of the individual components.

In the field of agriculture, it is often understood that the term “synergy” is as defined by Colby S.R. in an article entitled “Calculation of the synergistic and antagonistic responses of herbicide combinations” published in the journal Weeds, 1967, 15, p.20-22, incorporated herein by reference in its entirety. The action expected for a given combination of two or three active components can be calculated as follows:

Example 1:
A combination comprising Pinoxaden, Imazethapyr and Acifluorfen sodium in a ratio of 1:1.5:3 was prepared and its efficacy was tested against mixed weed flora in soybean crop in the following manner.
Crop : Soybean (Glycine max)
Target weeds : mixed weed flora (Grasses, broad leaf)
Number of Treatments: 11
Plot size : 6 m x 4 m=28 sq.m.
Application time :14 DAS (days after sowing), 2 to 4 leaf stage of weeds.
Application method : foliar spray with backpack sprayer attached flat fan nozzle.
Water volume : 400 liter per hectare
Observation Methods: Weed control (%): Species wise weed count recorded at 15 and 30 DAA (Days after Application) by using 0.25 m2 (50 cm x 50 cm) quadrant, treatment wise in minimum 5 places randomly selected in the plot. The species wise weed count further grouped into Grasses and Broad Leaf weeds (BLW) and sedges. The data presented here as total weed control (grasses+broad leaf+sedges). The average of each variable was used together with the sum of all the variables per plot to calculate the percentage of control.

Phytotoxicity: The observations on crop safety i.e., phytotoxicity or adverse effect of treatments were recorded at regular intervals. All the visual phytotoxicity symptoms like plant yellowing, leaf scorching, tip burning, bleaching, necrosis, stunting, crinkling, epinasty, hyponasty. Three leaves from each selected plant were scored using 0-10 rating scale, whereas 0=No injury/phytotoxicity, 1=1 to 10% phytotoxicity, 2=11 to 20%, 3=21 to 30%.......10=91 to 100% phytotoxicity. Percent phytotoxicity was determined using following formula.

Pod counts: Count the number of pods per plant from randomly selected 25 plants per plot at the time of harvest.

Table 1: Synergistic Composition
Sr.no. Treatments Application Rate (gai/h)


T1 Pinoxaden +Imazethapyr +Acifluorfen sodium 50+75+150
T2 Pinoxaden +Imazethapyr 50+75
T3 Pinoxaden +Acifluorfen sodium 50+150
T4 Imazethapyr +Acifluorfen sodium 75+150
T5 Clodinafop propargy+Acifluorfen sodium 80+165
T6 Quizalofop ethyl + Imazethapyr 32.81+65.625
T7 Propaquizafop + Imazethapyr 50+75
T8 Pinoxaden 50
T9 Imazethapyr 75
T10 Acifluorfen sodium 150
T11 Untreated Check (UTC) 0

Weed flora composition of trial plot: grassy weeds (Echinochloa colona, Eragrostis major) comprises of approximately 50% of total weed density (by count), broad leaf weeds (Commelina benghalensis, Cynotis spp., Phyllanthus niruri ) comprises 50% of weed density

Table 2: Control of mixed weed flora.
Sr.no. Weed control (%) Number of pods per plant Increase (%) in pods/plant over T11
15 DAA 30 DAA
observed Expected Colby ratio Synergism (Y/N)
T1 100.0 87.0 1.15 Y 99.6 44.5 75.89
T2 78.6 74.1 1.06 Y 70.8 38.8 53.36
T3 85.2 75.8 1.12 Y 67.8 39.1 54.55
T4 77.4 73.1 1.06 Y 69.8 39.4 55.73
T5 84.3 - - - 80.2 40.1 58.50
T6 80.7 - - - 79.2 38.5 52.17
T7 82.6 - - - 81.2 39.9 57.71
T8 51.7 - - - 48.2 30.6 20.95
T9 46.4 - - - 45.8 31.5 24.51
T10 49.8 - - - 45.2 30.2 19.37
T11 0.0 - - - 0.0 25.3 0.00

The field trial results show that present composition (T1) provides synergistic and residual control of mixed weed flora up to 30 DAA (days after application). Initial visual observations show speed of kill of weeds was observed faster in with present composition (T1) as compared with all prior art T5 to T7) and dual treatments (T2, T3 and T4) solo treatments (T8 to T10). At 30 days, it was observed that present composition (T1) effectively controls second flush of weeds (newly germinated weeds). The plot treated with present composition (T1) also bears highest number of pods per plant as compared all prior art treatments (T2 to T7) and solo treatments (T8 to T10).

Table 3: Phytotoxicity symptoms.
Sr.no. Phytotoxicity rating
leaf scorching (%) yellowing (%)
3 DAA 7 DAA 15 DAA 3 DAA 7 DAA 15 DAA
T1 10 5 0 5 5 0
T2 0 0 0 5 5 0
T3 10 5 0 0 0 0
T4 10 5 0 10 10 5
T5 10 5 0 5 5 0
T6 0 0 0 5 5 0
T7 0 0 0 5 5 0
T8 0 0 0 0 0 0
T9 0 0 0 5 5 0
T10 10 5 0 0 0 0
T11 0 0 0 0 0 0

The present composition (T1) causes little scorching and yellowing which was completely recovered without affecting normal plant growth at 15 DAA.
Thus, the combination is synergistic and is also not phytotoxic.

Example 2:
Since, the combination comprising Pinoxaden, Imazethapyr and Acifluorfen sodium in a ratio of 1:1.5:3 was found to be synergistic, a composition in the form of EC formulation comprising the aforesaid active ingredients in the aforesaid ratio was prepared. The other ingredients in the composition and their Wt% is provided in Table 2.

Table 4:
Chemical composition Function Percent (w/w)
Pinoxaden a.i Active Ingredient 5.00
Imazethapyr a.i. Active Ingredient 7.50
Acifluorfen sodium a.i. Active Ingredient 15.00
Cloquintocet mexyl Safener 1.25
Polyalkyleneoxide modified trisiloxane Wetting Agent 5.00
Tristyrylphenol Ethoxylate Phosphate Ester Emulsifier-I 9.75
Polyalkoxylated butyl ether Emulsifier-II 4.25
Calcium salt of alkylbenzene sulfonate Emulsifier-III 1.47
N-methylpyrrolidone Solvent-I 7.45
Tetrahydro-furan-2yl-methanol Solvent-II 18.62
Solvent Naphtha Solvent-III 24.71
Total 100.00

The process for preparing the EC formulation comprised of:
• Charge solvent Tetrahydrofurfuryl alcohol (18.62 kg), N-methylpyrrolidone (7.45 kg) and Solvent Naphtha (24.71 kg) into the vessel and then Pinoxaden technical (5.00 kg), Imazethapyr technical (7.50 kg), Acifluorfen technical (15.00 kg) and Cloquintocet mexyl (1.25 kg) slowly and mix thoroughly till it get dissolved completely.
• Now add Tristyrylphenol ethoxylate phosphate ester (9.75 kg), Polyalkoxylated butyl ether (4.25 kg) and Calcium salt of alkylbenzene sulfonate (1.47 kg) into this premix slowly and homogenised to get uniform solution.
• Finally add Polyalkyleneoxide modified trisiloxane (5 kg) and mix thoroughly get uniform clear solution and then send to QC for quality check

Example 3:
The EC formulation as prepared in example 2 was subjected to stability test at multiple temperatures and the results are provided in Table 5

Table 5
Storage Stability: Pinoxaden 5%+Imazethapyr 7.5%+Acifluorfen sodium 15% EC

Laboratory storage stability for 14 days
Parameters Specification (in house) Initial Stability at 54±2 0C Stability at 0±2 0C
Pinoxaden a.i. 5 5 4.98 5
Imazethapyr a.i. 7.5 7.5 7.49 7.5
Acifluorfen sodium a.i. 15 15 14.98 15
pH range (1% aq. Suspension) 4 to 9 5.20 5.21 5.20
Emulsion stability Stable Stable Stable Stable
Persistent foam ml (after 1 minute) max. 60 27 27 27

The EC formulation as prepared in example 2 was subjected to stability test for prolonged period of time and the results are provided in table 6.

Table 6
Room temperature storage stability up to 12 months
Parameters Specification (in house) Initial 1 month 6 month 12 month
Pinoxaden a.i. 5 5 5 4.99 4.97
Imazethapyr a.i. 7.5 7.5 7.5 7.49 7.49
Acifluorfen sodium a.i. 15 15 15 14.99 14.98
pH range (1% aq. Suspension) 4 to 9 5.20 5.20 5.21 5.22
Emulsion stability Stable Stable Stable Stable Stable
Persistent foam ml (after 1 minute) max. 60 27 27 27 27
The composition of Pinoxaden 5%+Imazethapyr 7.5%+Acifluorfen sodium 15% EC meets the all inhouse specifications for storage stability studies in laboratory (at 54±2 C & At 0±2 C for 14 days) and room temperature (for 12 months).

From the aforesaid it can be seen that the EC formulation comprising the synergistic combination of Pinoxaden, Imazethapyr and Acifluorfen sodium can be easily manufacture and satisfies the general storage requirements.

Example 4
A combination comprising Pinoxaden, Imazethapyr and Fomesafen sodium in a ratio of 1:1.5: 3.4 was prepared and its efficacy was tested against mixed weed flora in soybean crop in the following manner.
Crop : Soybean (Glycine max)
Target weeds : mixed weed flora (Grasses, broad leaf)
Number of Treatments: 12
Plot size : 6 m x 5 m=30 sq.m.
Application time :18 DAS (days after sowing), 3 to 5 leaf stage of weeds.
Application method : foliar spray with backpack sprayer attached flat fan nozzle.
Water volume : 400 liter per hectare

Table 7. Synergistic composition of ME1 formulation

Sr.no. Treatments Application Rate (gai/h)


T1 Pinoxaden + Imazethapyr + Fomesafen sodium 50+75+170
T2 Pinoxaden +Imazethapyr 50+75
T3 Pinoxaden +Fomesafen sodium 50+170
T4 Imazethapyr +Fomesafen sodium 75+170
T5 Quizalofop ethyl +Fomesafen 45+180
T6 Quizalofop ethyl + Imazethapyr 32.81+65.625
T7 Propaquizafop + Imazethapyr 50+75
T8 Clodinofop propargyl +Fomesafen 125+175
T9 Pinoxaden 50
T10 Imazethapyr 75
T11 Fomesafen sodium
150
T12 Untreated Check (UTC) 0

Weed flora composition of trial plot: grassy weeds (Echinochloa colona, Eleusine indica major) comprises of approximately 45% of total weed density (by count), broad leaf weeds (Commelina benghalensis, Commelina communis, Euphorbia geniculata) comprises 55% of weed density.

Table 8
Sr.no. Weed control (%) Number of pods per plant Increase (%) in pods/plant over T11
15 DAA 30 DAA
observed Expected Colby ratio Synergism (Y/N)
T1 100.0 85.5 1.17 Y 100.0 43.9 87.61
T2 69.5 68.8 1.01 Y 70.2 37.5 60.26
T3 80.2 74.9 1.07 Y 78.4 37.2 58.97
T4 84.5 73.3 1.15 Y 70.6 38.1 62.82
T5 82.3 - - - 80.2 38.8 65.81
T6 78.6 - - - 75.3 39.1 67.09
T7 79.7 - - - 76.9 38.7 65.38
T8 80.5 - - - 78.3 37.5 60.26
T9 45.8 - - - 44.6 29.7 26.92
T10 42.4 - - - 41.9 30.2 29.06
T11 53.7 - - - 50.6 29.4 25.64
T12 0.0 - - - 0.0 23.4 0.00

The present composition (T1) provides synergistic and residual control of mixed weed flora up to 30 DAA (days after application). Initial visual observations show speed of kill of weeds was observed faster in with present composition (T1) as compared with all prior art i.e. T5 to T8) dual treatments i.e.(T2 to T4) and solo treatments (T9 to T11). At 30 days, it was observed that present composition (T1) effectively controls second flush of weeds (newly germinated weeds). The plot treated with present composition (T1) also bears highest number of pods per plant as compared all prior art treatments (T2 to T8) and solo treatments (T9 to T11). The present composition (T1) caused 10% yellowing and scorching symptoms on soybean which were completely recovers on 15th day, without affecting normal plant growth

Example 5:
Since, the combination comprising Pinoxaden, Imazethapyr and Fomesafen sodium in a ratio of 1:1.5:3.4 was found to be synergistic, a composition in the form of ME formulation comprising ME1 the aforesaid active ingredients in the aforesaid ratio was prepared. The other ingredients in the composition and their Wt% is provided in Table 9.

Table 9
Chemical composition Function Percent (w/w)
Pinoxaden a.i Active Ingredient 2.50
Imazethapyr a.i. Active Ingredient 3.75
Fomesafen sodium a.i. Active Ingredient 8.50
Cloquintocet mexyl Safener 0.63
Polyalkyleneoxide modified trisiloxane Emulsifier-I 5.00
Polyoxyethylene sorbitan monooleate Emulsifier-II 18.85
Ricinoleic acid ethoxylate Emulsifier-III 18.15
Calcium salt of alkylbenzene sulfonate Emulsifier-IV 2.24
Isobutanol Solvent-I 5.23
N-methylpyrrolidone Solvent-II 4.24
Water Impurity 5.13
Tetrahydro-furan-2yl-methanol Solvent-III 25.78
Total 100.00

The process for preparing the ME1 formulation comprised of:

? Charge solvent Tetrahydrofurfuryl alcohol (25.78 kg), N-methylpyrrolidone (4.24 kg) and Isobutanol (5.23 kg) into the vessel and then Pinoxaden technical (2.50 kg), Imazethapyr technical (3.75 kg), Fomesafen sodium technical (8.50 kg) and Cloquintocet mexyl (0.63 kg) slowly and mix thoroughly till it get dissolved completely
? Now add Polyoxyethylene sorbitan monooleate (18.85 kg), Ricinoleic acid ethoxylate (18.15 kg) and Calcium salt of alkylbenzene sulfonate (2.24 kg) into this premix slowly and homogenised to get uniform solution.
? Finally add Polyalkyleneoxide modified trisiloxane (5 kg) and mix thoroughly get uniform clear solution and then send to QC for quality check

Example 6:
The ME1 formulation as prepared in example 5 was subjected to stability test at multiple temperatures and the results are provided in Table 10.
Table 10

Storage Stability: Pinoxaden 2.5%+Imazethapyr 3.75%+Fomesafen sodium 8.5% ME
Laboratory storage stability for 14 days
Parameters Specification (in house) Initial Stability at 54±2 0C Stability at 0±2 0C
Pinoxaden a.i. 2.5 2.5 2.46 2.5
Imazethapyr a.i. 3.75 3.75 3.73 3.75
Fomesafen sodium a.i. 8.5 8.5 8.47 8.5
pH range (1% Emulsion) 4 to 9 5.10 5.12 5.10
Emulsion Stability Stable Stable Stable Stable
Specific Gravity 1.01 to 1.05 1.02 1.02 1.02
Persistent foam ml (after 1 minute) max. 60 25 25 25

The ME1 formulation as prepared in example 5 was subjected to stability test for prolonged period of time and the results are provided in table 11

Table 11
Room temperature storage stability up to 12 months
Parameters Specification (in house) Initial 1 month 6 month 12 month
Pinoxaden a.i. 2.5 2.5 2.49 2.48 2.45
Imazethapyr a.i. 3.75 3.75 3.75 3.74 3.72
Fomesafen sodium a.i. 8.5 8.5 8.49 8.47 8.44
pH range (1% Emulsion) 5 to 9 5.10 5.10 5.10 5.12
Emulsion Stability 0.45-0.85 Stable Stable Stable Stable
Specific Gravity Max 3.0% 1.02 1.02 1.02 1.02
Persistent foam ml (after 1 minute) max. 60 25 25 25 25.00
The composition of Pinoxaden 2.5%+Imazethapyr 3.75%+Fomesafen sodium 8.5% ME meets the all inhouse specifications for storage stability studies in laboratory (at 54±2 C & At 0±2 C for 14 days) and room temperature (for 12 months).

From the aforesaid it can be seen that the ME1 formulation comprising the synergistic combination of
Pinoxaden, Imazethapyr and Fomesafen sodium can be easily manufacture and satisfies the general storage requirements.

Example: 7
A combination comprising Pinoxaden, Chlorimuron Ethyl and Fomesafen sodium in a ratio of 1: 0.16: 3.6 and a second composition comprising Pinoxaden, Chlorimuron Ethyl and Fomesafen sodium in a ratio of 1: 0.16: 3.4 was prepared and their efficacy was tested against mixed weed flora in soybean crop in the following manner.

Crop : Soybean (Glycine max)
Target weeds : mixed weed flora (Grasses, broad leaf)
Number of Treatments: 12
Plot size : 8 m x 4 m=32 sq.m.
Application time :15 DAS (days after sowing), 2 to 5 leaf stages of weeds.
Application method : foliar spray with backpack sprayer attached flat fan nozzle.
Water volume : 400 liters per hectare

Table 12. Synergistic composition
Sr.no. Treatment compositions Application Rate (gai/h)


T1 Pinoxaden + Chlorimuron Ethyl +Fomesafen sodium 50+8+180
T2 Pinoxaden + Chlorimuron Ethyl +Fomesafen sodium 50+8+170
T3 Pinoxaden + Chlorimuron 50+8
T4 Pinoxaden +Fomesafen sodium 50+180
T5 Chlorimuron Ethyl + Fomesafen sodium 8+180
T6 Pinoxaden 50
T7 Chlorimuron ethyl 8
T8 Fomesafen sodium 180
T9 Fomesafen sodium 170
T10 Untreated Check (UTC) 0

Weed flora composition of trial plot: grassy weeds (Echinochloa colona,Digitaira sanguinalis) comprises of approximately 45% of total weed density (by count), broad leaf weeds (Commelina benghalensis, Digera arvensis, Amaranthus viridis) comprises 55% of weed density.

Table 13
Sr.no. Weed control (%)
15 DAA 30 DAA
observed Expected Colby ratio Synergism (Y/N)
T1 98.8.0 88.27 1.12 Y 98.8
T2 100 88.11 1.15 Y 100
T3 79.5 73.5 1.08 Y 75.8
T4 80.8 76.4 1.06 Y 72.7
T5 56.8 78.0 0.73 Y 58.2
T6 46.7 - - - 45.2
T7 50.2 - - - 48.7
T8 55.8 - - - 53.2
T9 55.2 - - 54.8
T10 0.0 - - - 0.0

The present composition (T1and T2) provides synergistic and residual control of mixed weed flora up to 30 DAA (days after application). The present composition (T1and T2) caused 10% yellowing and scorching symptoms on soybean which were completely recovers on 15th day, without affecting normal plant growth.

Example: 8
Since, the first combination comprising Pinoxaden, Chlorimuron Ethyl and Fomesafen sodium in a ratio of 1: 0.16: 3.6 was found to be synergistic, a composition in the form of WG formulation (WG1) comprising the aforesaid active ingredients in the aforesaid ratio was prepared. The other ingredients in the composition and their Wt% is provided in Table 14.

Table 14
Chemical composition Function Percent (w/w)
Pinoxaden a.i Active Ingredient 5.00
Chlorimuron Ethyl a.i. Active Ingredient 0.80
Fomesafen sodium a.i. Active Ingredient 18.00
Modified Sodium lignosulphonate Dispersing Agent-I 7.47
Modified polyacrylate copolymer Dispersing Agent-II 5.23
Sodium isopropyl naphthalene sulfonate Wetting Agent 3.16
Polydimethylsiloxane Antifoaming Agent 0.50
Corn Starch Binding Agent 25.00
China clay Filler 34.84
Total 100.00

The process of preparing the WG1 composition comprising the steps of:

? Charge the 34.84 kg China clay, 25.00 kg Corn starch, 0.5 kg Polydimethylsiloxane, 3.16 kg of Sodium isopropyl naphthalene sulfonate, 5.23 kg Modified polyacrylate copolymer and 7.47 kg of Modified Sodium lignosulphonate blend into a ribbon or premix blender and homogenization for 30 minutes;
? Now charge 5.00 kg Pinoxaden technical, 00.80 kg chlorimuron ethyl technical and 18.00 kg Fomesafen sodium technical and again homogenize for 30 minutes and now this Pre-blended material is then grinded through Jet mill/ air classifier mills. Finely grinded material is blended in post blender till it becomes homogeneous. (for approx 1.5 hr)
? Finely grinded powder is mixed with 10 kg to 20 kg of water having 0.02 kg silicone antifoam to form extrudable dough.
? Dough is passed through extruder to get granules of required size.
? Wet granules are passed through Fluidized bed drier to remove extra water added and further graded using vibrating screens.
? Final product is sent for QC approval.
? After approval material is packed in required pack sizes.

Example 9:
The WG1 formulation as prepared in example 8 was subjected to stability test at multiple temperatures and the results are provided in Table 15.

Table 15
Storage Stability: Pinoxaden 5%+Chlorimuron Ethyl 0.8%+Fomesafen sodium 18% WG
Laboratory storage stability for 14 days
Parameters Specification (in house) Initial Stability at 54±2 0C Stability at 0±2 0C
Pinoxaden a.i. 5 5 4.99 5
Chlorimuron Ethyl a.i. 0.8 0.8 0.79 0.8
Fomesafen sodium a.i. 18 18 17.98 18
Pinoxaden suspensibility (%) 70 91.73 90.89 91.73
Chlorimuron Ethyl suspensibility (%) 70 89.12 88.75 89.12
Fomesafen sodium suspensibility (%) 70 97.43 97.12 97.43
pH range (1% aq. Suspension) 5 to 9 7.35 7.37 7.35
Wettability Max 60 s 25 27 25
Wet Sieve (45 micron) Mini 98.5% 99.5 99.5 99.5
Moisture Content Max 3.0% 2.1 1.9 2.1
Persistent foam ml (after 1 minute) max. 60 20 22 20

The WG1 formulation as prepared in example 8 was subjected to stability test for prolonged period of time and the results are provided in table 11.

Table 16
Room temperature storage stability up to 12 months
Parameters Specification (in house) Initial 1 month 6 month 12 month
Pinoxaden a.i. 5 5 5 4.99 4.79
Chlorimuron Ethyl a.i. 0.8 0.8 0.8 0.79 0.77
Fomesafen sodium a.i. 18 18 18 17.99 17.98
Pinoxaden suspensibility (%) 70 91.73 91.72 91.70 91.68
Chlorimuron Ethyl suspensibility (%) 70 89.12 89.12 89.09 89.02
Fomesafen sodium suspensibility (%) 70 97.43 97.43 97.44 97.42
pH range (1% aq. Suspension) 5 to 9 7.35 7.35 7.37 7.37
Wettability Max 60 s 25 25 25 27
Wet Sieve (45 micron) Mini 98.5% 99.5 99.5 99.5 99.5
Moisture Content Max 3.0% 2.1 2 1.9 1.9
Persistent foam ml (after 1 minute) max. 60 20 20 22 25
The composition of Pinoxaden 5%+Chlorimuron Ethyl 0.8%+Fomesafen sodium 18% WG meets the all inhouse specifications for storage stability studies in laboratory (at 54±2 C & At 0±2 C for 14 days) and room temperature (for 12 months).

From the aforesaid it can be seen that the WG1 formulation comprising the synergistic combination of
Pinoxaden, Chlorimuron Ethyl and Fomesafen sodium can be easily manufacture and satisfies the general storage requirements.

Example 11:
Since, the second combination comprising Pinoxaden, Chlorimuron Ethyl and Fomesafen sodium in a ratio of 1: 0.16: 3.4 was found to be synergistic, a composition in the form of ME formulation (ME2) comprising the aforesaid active ingredients in the aforesaid ratio was prepared. The other ingredients in the composition that and their Wt% is provided in Table 17.

Table 17
Chemical composition Function Percent (w/w)
Pinoxaden a.i Active Ingredient 5.00
Chlorimuron Ethyl a.i. Active Ingredient 0.80
Fomesafen sodium a.i. Active Ingredient 17.00
Cloquintocet mexyl Safener 1.25
Polyalkyleneoxide modified trisiloxane Wetting Agent 5.00
Tristyrylphenol ethoxylate Emulsifier-I 16.67
Vegetable oil ethoxylates Emulsifier-II 17.45
Calcium salt of alkylbenzene sulfonate Emulsifier-III 2.35
N-methylpyrrolidone Solvent 3.78
Propylene carbonate Solvent 4.75
Water Impurity 7.87
Tetrahydro-furan-2yl-methanol Solvent 18.08
Total 100.00

The process for preparing the ME2 formulation comprised of:

? Charge solvent Tetrahydrofurfuryl alcohol (18.08 kg), N-methylpyrrolidone (3.78 kg) and Propylene carbonate (4.75 kg) into the vessel and then Pinoxaden technical (5.00 kg), Chlorimuron ethyl technical (0.80 kg), Fomesafen sodium technical (17.00 kg) and Cloquintocet mexyl (1.25 kg) slowly and mix thoroughly till it get dissolved completely.
? Now add Tristyrylphenol ethoxylate (16.67 kg), Vegetable oil ethoxylate (17.45 kg) and Calcium salt of alkylbenzene sulfonate (2.35 kg) into this premix slowly and homogenised to get uniform solution.
? Finally add Polyalkyleneoxide modified trisiloxane (5 kg) and mix thoroughly get uniform clear solution and then send to QC for quality check.

Example 12:
The ME2 formulation as prepared in example 11 was subjected to stability test at multiple temperatures and the results are provided in Table 18.
Table 18

Storage Stability: Pinoxaden 5%+Chlorimuron ethyl 0.8%+Fomesafen sodium 17% ME
Laboratory storage stability for 14 days
Parameters Specification (in house) Initial Stability at 54±2 0C Stability at 0±2 0C
Pinoxaden a.i. 5 5 4.96 5
Chlorimuron Ethyl a.i. 0.8 0.8 0.75 0.8
Fomesafen sodium a.i. 17 17 16.95 17
pH range (1% Emulsion) 4 to 9 6.20 6.22 6.20
Emulsion Stability Stable Stable Stable Stable
Specific Gravity 1.01 to 1.05 1.02 1.02 1.02
Persistent foam ml (after 1 minute) max. 60 27.00 27.00 27.00

The ME2 formulation as prepared in example 11 was subjected to stability test for prolonged period of time and the results are provided in table 19

Table 19
Room temperature storage stability up to 12 months
Parameters Specification (in house) Initial 1 month 6 month 12 month
Pinoxaden a.i. 5 5 4.99 4.98 4.97
Chlorimuron Ethyl a.i. 0.8 0.8 0.79 0.78 0.76
Fomesafen sodium a.i. 17 17 17 16.98 16.96
pH range (1% Emulsion) 4 to 9 6.20 6.20 6.21 6.22
Emulsion Stability Stable Stable Stable Stable Stable
Specific Gravity 1.01 to 1.05 1.02 1.02 1.02 1.02
Persistent foam ml (after 1 minute) max. 60 27.00 27.00 27.00 27.00
The composition of Pinoxaden 5%+Chlorimuron ethyl 0.8%+Fomesafen sodium 17% ME meets the all inhouse specifications for storage stability studies in laboratory (at 54±2 C & At 0±2 C for 14 days) and room temperature (for 12 months).

From the aforesaid it can be seen that the ME2 formulation comprising the synergistic combination of
Pinoxaden, Imazethapyr and Fomesafen sodium can be easily manufacture and satisfies the general storage requirements.

Example: 13
A combination comprising Pinoxaden, Chlorimuron Ethyl and Imazethapyr in a ratio of 2: 0.32: 3 was prepared and its efficacy was tested against mixed weed flora in soybean crop in the following manner.

Crop : Soybean (Glycine max)
Target weeds : mixed weed flora (Grasses, broad leaf)
Number of Treatments: 12
Plot size : 8 m x 4 m=32 sq.m.
Application time :15 DAS (days after sowing), 2 to 5 leaf stages of weeds.
Application method : foliar spray with backpack sprayer attached flat fan nozzle.
Water volume : 400 liters per hectare

Table 20. Synergistic composition of WG2 formulation
Sr.no. Treatment compositions Application Rate (gai/h)


T1 Pinoxaden +Chlorimuron Ethyl +Imazethapyr 50+8+75
T2 Pinoxaden +Chlorimuron 50+8
T3 Pinoxaden +Imazethapyr 50+75
T4 Chlorimuron Ethyl +Imazethapyr 8+75
T5 Pinoxaden EC 50
T6 Chlorimuron ethyl 8
T7 Imazethapyr 75
T8 Untreated Check (UTC) 0

Weed flora composition of trial plot: grassy weeds (Echinochloa colona,Digitaira sanguinalis) comprises of approximately 45% of total weed density (by count), broad leaf weeds (Commelina benghalensis, Digera arvensis, Amaranthus viridis) comprises 55% of weed density.

Table 21
Sr.no. Weed control (%)
15 DAA 30 DAA
observed Expected Colby ratio Synergism (Y/N)
T1 100.0 86.3 1.16 Y 100.0
T2 79.5 73.5 1.08 Y 75.8
T3 81.2 72.4 1.12 Y 71.6
T4 65.6 74.3 0.88 Y 68.2
T5 46.7 - - - 45.2
T6 50.2 - - - 48.7
T7 48.3 - - - 45.6
T8 0.0 - - - 0.0

The present composition (T1) provides synergistic and residual control of mixed weed flora up to 30 DAA (days after application). The present composition (T1) caused 10% yellowing and scorching symptoms on soybean which were completely recovers on 15th day, without affecting normal plant growth.

Example: 14
Since, the combination comprising Pinoxaden, Chlorimuron Ethyl and Imazethapyr in a ratio of 2: 0.32: 3 was found to be synergistic, a composition in the form of WG formulation (WG2) comprising the aforesaid active ingredients in the aforesaid ratio was prepared. The other ingredients in the composition that and their Wt% is provided in Table 22.

Table 22
Chemical composition Function Percent (w/w)
Pinoxaden a.i Active Ingredient 10.00
Chlorimuron Ethyl a.i. Active Ingredient 1.60
Imazethapyr a.i. Active Ingredient 15.00
sodium salt of naphthalene sulfonate condensate Dispersing Agent-I 7.22
Sodium Polycarboxylate Dispersing Agent-II 4.74
Diisobutyl naphthalene sulfonate, sodium salt Wetting Agent 4.75
Polydimethylsiloxane Antifoaming Agent 0.50
Lactose anhydrous Binding Agent 17.45
Kaolin Clay Filler 38.74
Total 100.00

The process of preparing the WG2 composition comprising the steps of:

? Charge the 38.74 kg Kaolin clay, 17.45 kg Lactose Anhydrous, 0.5 kg Polydimethylsiloxane, 4.75 kg of Diisobutyl naphthalene sulfonate sodium salt, 7.22 kg Sodium salt of naphthalene sulfonate condensate and 4.74 kg of Sodium polycarboxylate into a ribbon or premix blender and homogenization for 30 minutes;
? Now charge 10.00 kg Pinoxaden technical, 1.60 kg Chlorimuron ethyl technical and 15.00 kg Imazethapyr technical and again homogenize for 30 minutes and now this Pre-blended material is then grinded through Jet mill/ air classifier mills. Finely grinded material is blended in post blender till it becomes homogeneous. (for approx 1.5 hr),
? Finely grinded powder is mixed with 10 kg to 20 kg of water having 0.02 kg silicone antifoam to form extrudable dough;
? Dough is passed through extruder to get granules of required size;
? Wet granules are passed through Fluidized bed drier to remove extra water added and further graded using vibrating screens;
? Final product is sent for QC approval;
? After approval material is packed in required pack sizes;

Example 15:
The WG2 formulation as prepared in example 14 was subjected to stability test at multiple temperatures and the results are provided in Table 23.

Table 23
Storage Stability: Pinoxaden 10%+Chlorimuron Ethyl 1.6%+Imazethapyr 15% WG


Laboratory storage stability for 14 days
Parameters Specification (in house) Initial Stability at 54±2 0C Stability at 0±2 0C
Pinoxaden a.i. 10 10 9.98 10
Chlorimuron Ethyl a.i. 1.6 1.6 1.56 1.6
Imazethapyr a.i. 15 15 14.96 15
Pinoxaden suspensibility (%) 70 92.71 92.45 92.71
Chlorimuron Ethyl suspensibility (%) 70 87.45 87.12 87.45
Imazethapyr suspensibility (%) 70 90.37 89.87 90.37
pH range (1% aq. Suspension) 5 to 9 6.12 6.19 6.12
Wettability Max 60 s 20 22 20
Wet Sieve (75 microns) Mini 98.5% 99.54 99.52 99.54
Moisture Content Max 3.0% 2.3 2.2 2.3
Persistent foam ml (after 1 minute) max. 60 20 24 20

The WG2 formulation as prepared in example 14 was subjected to stability test for prolonged period of time and the results are provided in table 24.

Table 24
Room temperature storage stability up to 12 months
Parameters Specification (in house) Initial 1 month 6 month 12 month
Pinoxaden a.i. 10 10 10 9.99 9.97
Chlorimuron Ethyl a.i. 1.6 1.6 1.6 1.59 1.56
Imazethapyr a.i. 15 15 15 15 14.98
Pinoxaden suspensibility (%) 70 92.71 92.71 92.70 91.87
Chlorimuron Ethyl suspensibility (%) 70 87.45 87.45 87.43 86.72
Imazethapyr suspensibility (%) 70 90.37 90.37 90.35 89.45
pH range (1% aq. Suspension) 5 to 9 6.12 6.12 6.13 6.15
Wettability Max 60 s 20 20 22 25
Wet Sieve (45 micron) Mini 98.5% 99.54 99.54 99.52 99.50
Moisture Content Max 3.0% 2.3 2.3 2.2 2.1
Persistent foam ml (after 1 minute) max. 60 20 20 20 22

From the aforesaid it can be seen that the WG2 formulation comprising the synergistic combination of
Pinoxaden, Chlorimuron Ethyl and Imazethapyr can be easily manufacture and satisfies the general storage requirements.

Example: 16
A combination comprising Pinoxaden, Imazethapyr and Imazethapyr in a ratio of 4: 3: 3 was prepared and its efficacy was tested against mixed weed flora in soybean crop in the following manner.

Crop : Groudnut
Target weeds : mixed weed flora (Grasses, broad leaf)
Number of Treatments: 6
Plot size : 8 m x 5 m=40 sq.m.
Application time :14 DAS (days after sowing), 2 to 4 leaf stages of weeds.
Application method : foliar spray with backpack sprayer attached flat fan nozzle.
Water volume : 375 liters per hectare

Table 25. Synergistic composition
Sr.no. Treatment compositions Application Rate (gai/h)
T1 Pinoxaden + Imazethapyr +Imazamox

50+37.5+37.5
T2 Imazethapyr +Imazamox 37.5+37.5
T3 Pinoxaden 50
T4 Imazethapyr 37.5
T5 Imazamox 37.5
T6 Untreated Check (UTC) 0

Table 26
Sr.no. Weed control (%)
15 DAA 30 DAA
observed Expected Colby ratio Synergism (Y/N)
T1 99.2 85.8 1.16 Y 98.8
T2 84.7 75.3 1.13 Y 78.6
T3 42.8 - - - 42.6
T4 52.6 - - - 48.5
T5 47.8 - - - 44.7
T6 0.0 - - - 0.0

The present composition (T1) provides synergistic and residual control of mixed weed flora up to 30 DAA (days after application).
The present composition (T1) caused 10% yellowing and scorching symptoms on groundnut which were completely recovers on 15th day, without affecting normal plant growth.

Example: 17
Since, the combination comprising Pinoxaden, Imazethapyr and Imazamox in a ratio of 4: 3: 3 was found to be synergistic, a composition in the form of WG formulation (WG3) comprising the aforesaid active ingredients in the aforesaid ratio was prepared. The other ingredients in the composition that and their Wt% is provided in Table 27.

Table 27
Chemical composition Function Percent (w/w)
Pinoxaden a.i Active Ingredient 20.00
Imazethapyr a.i. Active Ingredient 15.00
Imazamox a.i. Active Ingredient 15.00
N-methyl oleyl taurate Dispersing Agent-I 4.75
Potassium Polycarboxylate Dispersing Agent-II 7.75
Sodium dioctylsulphosuccinate Wetting Agent 4.47
Polydimethylsiloxane Antifoaming Agent 0.50
Precipitated Silica Antihumactant 1.78
Diatomaceous earth Binding Agent 5.13
Sodium bicarbonate Buffering Agent 4.45
China clay Filler 21.17
Total 100.00

The process of preparing the WG3 composition comprising the steps of:

? Charge the 38.74 kg Kaolin clay, 17.45 kg Lactose Anhydrous, 0.5 kg Polydimethylsiloxane, 4.75 kg of Diisobutyl naphthalene sulfonate sodium salt, 7.22 kg Sodium salt of naphthalene sulfonate condensate and 4.74 kg of Sodium polycarboxylate into a ribbon or premix blender and homogenization for 30 minutes;
? Now charge 10.00 kg Pinoxaden technical, 1.60 kg Chlorimuron ethyl technical and 15.00 kg Imazethapyr technical and again homogenize for 30 minutes and now this Pre-blended material is then grinded through Jet mill/ air classifier mills. Finely grinded material is blended in post blender till it becomes homogeneous. (for approx 1.5 hr),
? Finely grinded powder is mixed with 10 kg to 20 kg of water having 0.02 kg silicone antifoam to form extrudable dough;
? Dough is passed through extruder to get granules of required size;
? Wet granules are passed through Fluidized bed drier to remove extra water added and further graded using vibrating screens;
? Final product is sent for QC approval;
? After approval material is packed in required pack sizes;

Example 18:
The WG3 formulation as prepared in example 17 was subjected to stability test at multiple temperatures and the results are provided in Table 28.

Table 28
Storage Stability: Pinoxaden 20%+Imazethapyr 15%+Imazamox 15% WG

Laboratory storage stability for 14 days
Parameters Specification (in house) Initial Stability at 54±2 0C Stability at 0±2 0C
Pinoxaden a.i. 20 20 19.98 20
Imazethapyr a.i. 15 15 14.99 15
Imazamox a.i. 15 15 14.97 15
Pinoxaden suspensibility (%) 70 89.78 89.12 89.78
Imazethapyr suspensibility (%) 70 91.23 90.79 91.23
Imazamox suspensibility (%) 70 90.45 90.11 90.45
pH range (1% aq. Suspension) 5 to 9 7.10 7.12 7.10
Wettability Max 60 s 15 17 15
Wet Sieve (45 micron) Mini 98.5% 99.7 99.6 99.7
Moisture Content Max 3.0% 1.5 1.4 1.5
Persistent foam ml (after 1 minute) max. 60 20 25 20

The WG3 formulation as prepared in example 17 was subjected to stability test for prolonged period of time and the results are provided in table 29.

Table 29

Room temperature storage stability up to 12 months
Parameters Specification (in house) Initial 1 month 6 month 12 month
Pinoxaden a.i. 20 20 20 19.99 19.97
Imazethapyr a.i. 15 15 15 14.99 14.97
Imazamox a.i. 15 15 15 14.99 14.97
Pinoxaden suspensibility (%) 70 89.78 89.78 89.54 89.23
Imazethapyr suspensibility (%) 70 91.23 91.23 91.09 90.74
Imazamox suspensibility (%) 70 90.45 90.45 90.31 89.81
pH range (1% aq. Suspension) 5 to 9 7.10 7.10 7.12 7.15
Wettability Max 60 s 15 15 17 20
Wet Sieve (75 microns) Mini 98.5% 99.7 99.7 99.6 99.5
Moisture Content Max 3.0% 1.5 1.5 1.3 1.2
Persistent foam ml (after 1 minute) max. 60 20 20 22 25

From the aforesaid it can be seen that the WG3 formulation comprising the synergistic combination of
Pinoxaden, Imazethapyr and Imazamox can be easily manufacture and satisfies the general storage requirements.

While the foregoing describes various embodiments of the disclosure, other and further embodiments of the disclosure may be devised without departing from the basic scope thereof. The invention is not limited to the described embodiments, versions or examples, which are included to enable a person having ordinary skill in the art to make and use the invention when combined with information and knowledge available to the person having ordinary skill in the art.

The foregoing embodiments are merely illustrative and are not to be taken as limitations upon the scope of the invention. Various changes and modifications to the disclosed embodiments will be apparent to those skilled in the art. Such changes and modifications may be made without departing from the scope of the invention.

ADVANTAGES OF THE INVENTION
The present invention provides a composition comprising combination of compounds having synergistic herbicidal effect.

The present invention provides a composition comprising herbicides, said composition being stable.

The present invention provides a composition comprising herbicide compounds for effective control of wide array of weeds.

The present disclosure provides a composition that can help delay, reduce and/or avoid the onset of herbicidal resistance or can be used on weeds already resistant to existing herbicides.
,CLAIMS:WE CLAIM:

1. A herbicide composition comprising;
• a first compound being pinoxaden;
• a second compound selected from chlorimuron ethyl, imazethapyr and combination thereof; and
• a third herbicidal compound that is different from the first compound and the second compound.

2. The herbicide composition as claimed in claim 1, wherein the ratio of first compound: second compound: third compound is 2 to 20: 0.25 to 40: 1 to 45 respectively.

3. The herbicide composition as claimed in claim 1, wherein the third compound is selected from a group comprising of fomesafen sodium, acifluorfen sodium, lactofen, bentazone, imazamox, imazethapyr, and mixtures thereof.

4. The herbicide composition as claimed in claim 1, being in a form selected from a group comprising of capsule suspension (CS), dispersible concentrate (DC), emulsifiable concentrate (EC), water-in-oil emulsion (EO), oil in water emulsion (EW), micro-emulsion (ME), oil dispersion (OD), oil miscible flowable concentrate, oil miscible suspension (OF), oil miscible liquid (OL), suspension concentrate (SC), suspo-emulsion (SE), soluble concentrate (SL), water dispersible granule (WG or WDG), water soluble granule (SG), water soluble powder (SP), wettable powder (WP), a mixed formulation of CS and SC (ZC), a mixed formulation of CS and SE (ZE) and a mixed formulation of CS and EW (ZW).

5. The herbicide composition as claimed in claim 4, wherein at least one of;
• the herbicidal composition being in form of capsule suspension (CS) formulation, the CS formulation comprises one or more of a wall forming agent, a dispersing agent, a wetting agent, a wetting-spreading-penetrating agent, a solvent, a thickener, a suspending agent, an antifoaming agent, an antifreezing agent, a preservative and a buffering agent,
• the herbicidal composition being in a form emulsifiable concentrate (EC) formulation comprise one or more of solvent, emulsifiers, wetting agent.
• the herbicidal composition being in a form of a micro-Emulsion (ME) formulation, the ME formulation comprises one or more of Solvent, Spreading cum wetting agent,
• the herbicidal composition being in a form an oil dispersion (OD) formulation, the OD formulation comprises one or more of super wetting-spreading-penetrating agent, solvent, dispersing agents, emulsifier, Stabilizers, Antifoaming agent, Anti-freezing agent, preservative, buffering agent, Polar Co-solvent,
• the herbicidal composition being in a form a suspension Concentrate (SC) formulation, the SC formulation comprises one or more of wetting agent, dispersing agent, Suspending agent, Antifoaming agent, Anti-freezing agent, Preservatives, Thickeners,
• the herbicidal composition being in a form of a Suspo Emulsion (SE) formulation, the SE formulation comprises one or more of Solvent, Emulsifier, Stabilizer, Anti-freezing agent, Antifoaming agent, suspending agent, Wetting agent, Wetting-spreading-penetrating agent, Preservatives, Thickeners, dispersing agent, Buffering agent,
• the herbicidal composition being in a form of a Wettable Granule (WG) formulation, the WG formulation comprises one or more of Dispersing agents, Wetting agents, Antifoaming agent, Carrier.

6. The herbicide composition as claimed in claim 1, wherein:
• the composition comprising Pinoxaden, Imazethapyr and acifluorfen sodium, a ratio between Pinoxaden: Imazethapyr: acifluorfen sodium being 1: 1.5: 3 and being in an EC formulation;
• the composition comprising Pinoxaden, Imazethapyr and Fomesafen sodium, a ratio between Pinoxaden: Imazethapyr: Fomesafen sodium being 1: 1.5: 3.4 and being in a ME formulation;
• the composition comprising Pinoxaden, Chlorimuron Ethyl and Fomesafen sodium, a ratio between Pinoxaden: Imazethapyr: Fomesafen sodium being 1: 0.16: 3.4 and being in a ME formulation;
• the composition comprising Pinoxaden, Chlorimuron Ethyl and Fomesafen sodium, a ratio between Pinoxaden: Chlorimuron Ethyl: Fomesafen sodium being 1: 0.16: 3.6 and being in a WG formulation;
• the composition comprising Pinoxaden, Chlorimuron Ethyl and Imazethapyr, a ratio between Pinoxaden: Chlorimuron Ethyl: Imazethapyr being 2: 0.32: 3 and being in a WG formulation; and
• the composition comprising Pinoxaden, Imazethapyr and Imazamox, a ratio between Pinoxaden: Imazethapyr: Imazamox being 4: 3: 3 and being in a WG formulation.

7. A process for preparation of a herbicide composition comprising;
• mixing the first compound pinoxaden;
• mixing the second compound chlorimuron ethyl, imazethapyr and combination thereof; and
• mixing the third herbicidal compound to obtain an herbicide composition.

8. The process as claimed in claim 7, wherein at least one of;
• a ratio of the first compound: second compound: third compound is 2 to 20: 0.25 to 40: 1 to 45;
• the third compound is selected from a group comprising of fomesafen sodium, acifluorfen sodium, lactofen, bentazone, imazamox, imazethapyr, and mixtures thereof;
• herbicide composition is in a form selected from a group comprising of capsule suspension (CS), dispersible concentrate (DC), emulsifiable concentrate (EC), water-in-oil emulsion (EO), oil in water emulsion (EW), micro-emulsion (ME), oil dispersion (OD), oil miscible flowable concentrate, oil miscible suspension (OF), oil miscible liquid (OL), suspension concentrate (SC), suspo-emulsion (SE), soluble concentrate (SL), water dispersible granule (WG or WDG), water soluble granule (SG), water soluble powder (SP), wettable powder (WP), a mixed formulation of CS and SC (ZC), a mixed formulation of CS and SE (ZE) and a mixed formulation of CS and EW (ZW).

9. The process as claimed in claim 7, wherein at least one of;
• the composition being an EC formulation comprising Pinoxaden, Imazethapyr and acifluorfen sodium, mixing Pinoxaden, Imazethapyr and acifluorfen sodium in a ratio between Pinoxaden: Imazethapyr: acifluorfen sodium 1: 1.5: 3 and a one more agriculturally acceptable excipient selected form a group comprising Emulsifiers, wetting agent in one or more solvent,
• the composition being an ME formulation comprising Pinoxaden, Imazethapyr and Fomesafen sodium, mixing Pinoxaden, Imazethapyr and Fomesafen sodium in a ratio between Pinoxaden: Imazethapyr: Fomesafen sodium 0.5: 0.75: 1.7 and a one more agriculturally acceptable excipient selected form the group emulsifier, in one or more solvent,
• the composition being an ME1formulation comprising Pinoxaden, Chlorimuron Ethyl and Fomesafen sodium, mixing Pinoxaden, Chlorimuron Ethyl and Fomesafen sodium in a ratio between Pinoxaden: Chlorimuron Ethyl: Fomesafen sodium 0.5: 0.75: 1.7 and a one more agriculturally acceptable excipient selected form the group emulsifier, in one or more solvent,
• the composition being an WG formulation comprising Pinoxaden, Chlorimuron Ethyl and Fomesafen sodium, mixing Pinoxaden, Chlorimuron Ethyl and Fomesafen sodium in a ratio between Pinoxaden: Chlorimuron Ethyl: Fomesafen sodium 1: 0.16: 3.6 and a one more agriculturally acceptable excipient selected form the group comprising one or more of Dispersing agents, Wetting agents, Antifoaming agent, Humectant in one or more Carrier,
• the composition being an WG formulation comprising Pinoxaden, Chlorimuron Ethyl and Imazethapyr, mixing Pinoxaden, Chlorimuron Ethyl and Imazethapyr in a ratio between Pinoxaden: Chlorimuron Ethyl: Imazethapyr 2: 0.32: 3 and a one more agriculturally acceptable excipient selected form the group comprising one or more of Dispersing agents, Wetting agents, Antifoaming agent, Humectant in one or more Carrier,
• the composition being an WG formulation comprising Pinoxaden: Imazethapyr: Imazamox, mixing Pinoxaden: Imazethapyr: Imazamox in a ratio between Pinoxaden: Imazethapyr: Imazamox 4: 3: 3 and a one more agriculturally acceptable excipient selected form the group comprising one or more of Dispersing agents, Wetting agents, Antifoaming agent, Humectant in one or more Carrier.

Documents

Application Documents

# Name Date
1 202421020589-STATEMENT OF UNDERTAKING (FORM 3) [19-03-2024(online)].pdf 2024-03-19
2 202421020589-PROVISIONAL SPECIFICATION [19-03-2024(online)].pdf 2024-03-19
3 202421020589-FORM FOR SMALL ENTITY(FORM-28) [19-03-2024(online)].pdf 2024-03-19
4 202421020589-FORM FOR SMALL ENTITY [19-03-2024(online)].pdf 2024-03-19
5 202421020589-FORM 1 [19-03-2024(online)].pdf 2024-03-19
6 202421020589-EVIDENCE FOR REGISTRATION UNDER SSI(FORM-28) [19-03-2024(online)].pdf 2024-03-19
7 202421020589-DECLARATION OF INVENTORSHIP (FORM 5) [19-03-2024(online)].pdf 2024-03-19
8 202421020589-FORM-26 [21-05-2024(online)].pdf 2024-05-21
9 202421020589-CORRESPONDENCE-OTHERS [18-03-2025(online)].pdf 2025-03-18
10 202421020589-COMPLETE SPECIFICATION [18-03-2025(online)].pdf 2025-03-18